Northrop, J. H. The influence of the intensity of light on the rate of growth and duration of life of Drosophila. J. Gen. Physiol. 9, 81–86 (1925).
Google Scholar
McCay, C. M., Maynard, L. A., Sperling, G. & Barnes, L. L. The Journal of Nutrition. Volume 18 July-December, 1939. Pages 1–13. Retarded growth, life span, ultimate body size and age changes in the albino rat after feeding diets restricted in calories. Nutr. Rev. 33, 241–243 (1975).
Google Scholar
Klass, M. R. A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results. Mech. Ageing Dev. 22, 279–286 (1983).
Google Scholar
Niccoli, T. & Partridge, L. Ageing as a risk factor for disease. Curr. Biol. 22, R741–R752 (2012).
Google Scholar
Wilkerson, H. L. Problems of an aging population: public health aspects of diabetes. Am. J. Public Health Nations Health 37, 177–188 (1947).
Google Scholar
Cortes-Canteli, M. & Iadecola, C. Alzheimer’s Disease and Vascular Aging: JACC Focus Seminar. J. Am. Coll. Cardiol. 75, 942–951 (2020).
Google Scholar
Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427–442 (1967).
Google Scholar
Kaufman, P. & Poliakoff, H. Studies on the aging heart; the pattern of rheumatic heart disease in old age (a clinical pathological study). Ann. Intern Med. 32, 889–904 (1950).
Google Scholar
Yan, M. et al. Cardiac aging: from basic research to therapeutics. Oxid. Med. Cell Longev. 2021, 9570325 (2021).
Google Scholar
Hernandez Cordero, A. I. et al. Airway aging and methylation disruptions in HIV-associated chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 206, 150–160 (2022).
Grunewald, M. et al. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science 373, eabc8479 (2021).
Chen, X. et al. METTL3-mediated m(6)A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann. Rheum. Dis. 81, 87–99 (2022).
Google Scholar
Ding, J. et al. The association between aging-related monocyte transcriptional networks and comorbidity burden: the multi-ethnic study of atherosclerosis (MESA). Geroscience (2022).
Bettonte, S., Berton, M. & Marzolini, C. Magnitude of drug-drug interactions in special populations. Pharmaceutics 14, 789 (2022).
Zhao, Y., Seluanov, A. & Gorbunova, V. Revelations about aging and disease from unconventional vertebrate model organisms. Annu. Rev. Genet. 55, 135–159 (2021).
Google Scholar
Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298–300 (1956).
Google Scholar
Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585–621 (1961).
Google Scholar
Li, Z. et al. Folic acid inhibits aging-induced telomere attrition and apoptosis in astrocytes in vivo and in vitro. Cereb. Cortex 32, 286–297 (2022).
Google Scholar
Bharath, L. P. et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 32, 44–55 e46 (2020).
Google Scholar
Tracy, T. E. et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell 185, 712–728.e714 (2022).
Google Scholar
Lei, J. et al. Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis. Protein Cell 13, 220–226 (2022).
Google Scholar
van der Laan, L. et al. Epigenetic aging biomarkers and occupational exposure to benzene, trichloroethylene and formaldehyde. Environ. Int. 158, 106871 (2022).
Google Scholar
Mossad, O. et al. Gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N(6)-carboxymethyllysine. Nat. Neurosci. 25, 295–305 (2022).
Google Scholar
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Google Scholar
Aman, Y. et al. Autophagy in healthy aging and disease. Nat. Aging 1, 634–650 (2021).
Google Scholar
Aguilera, A. & Garcia-Muse, T. Causes of genome instability. Annu. Rev. Genet. 47, 1–32 (2013).
Google Scholar
Siametis, A., Niotis, G. & Garinis, G. A. DNA damage and the aging epigenome. J. Invest. Dermatol. 141, 961–967 (2021).
Google Scholar
Williams, A. B. & Schumacher, B. p53 in the DNA-damage-repair process. Cold Spring Har. Perspect. Med. 6, a026070 (2016).
Regulski, M. J. Cellular senescence: what, why, and how. Wounds 29, 168–174 (2017).
Hou, J. et al. Aging with higher fractional exhaled nitric oxide levels are associated with increased urinary 8-oxo-7,8-dihydro-2’-deoxyguanosine concentrations in elder females. Environ. Sci. Pollut. Res. Int. 23, 23815–23824 (2016).
Google Scholar
Gorini, F. et al. The genomic landscape of 8-oxodG reveals enrichment at specific inherently fragile promoters. Nucleic Acids Res. 48, 4309–4324 (2020).
Google Scholar
Tabula Muris, C. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature 583, 590–595 (2020).
Google Scholar
Sanchez-Roman, I. et al. Molecular markers of DNA repair and brain metabolism correlate with cognition in centenarians. GeroScience 44, 103–125 (2022).
Google Scholar
Storci, G. et al. Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians. Cell Death Differ. 26, 1845–1858 (2019).
Google Scholar
Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813–827 (2019).
Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402–406 (2017).
Google Scholar
Kauppila, T. E. S., Kauppila, J. H. K. & Larsson, N. G. Mammalian mitochondria and aging: an update. Cell Metab. 25, 57–71 (2017).
Google Scholar
Son, J. M. & Lee, C. Mitochondria: multifaceted regulators of aging. BMB Rep. 52, 13–23 (2019).
Google Scholar
Chiang, J. L. et al. Mitochondria in ovarian aging and reproductive longevity. Ageing Res. Rev. 63, 101168 (2020).
Google Scholar
Quan, Y., Xin, Y., Tian, G., Zhou, J. & Liu, X. Mitochondrial ROS-modulated mtDNA: a potential target for cardiac aging. Oxid. Med. Cell Longev. 2020, 9423593 (2020).
Google Scholar
Yu, C. H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell 183, 636–649.e618 (2020).
Google Scholar
Loo, T. M., Miyata, K., Tanaka, Y. & Takahashi, A. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer. Cancer Sci. 111, 304–311 (2020).
Google Scholar
Son, J. M. & Lee, C. Aging: all roads lead to mitochondria. Semin. Cell Dev. Biol. 116, 160–168 (2021).
Google Scholar
Jauhari, A. et al. Melatonin inhibits cytosolic mitochondrial DNA-induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J. Clin. Invest. 130, 3124–3136 (2020).
Google Scholar
Gonzalo, S., Kreienkamp, R. & Askjaer, P. Hutchinson-Gilford progeria syndrome: a premature aging disease caused by LMNA gene mutations. Ageing Res. Rev. 33, 18–29 (2017).
Google Scholar
Bin Imtiaz, M. K. et al. Declining lamin B1 expression mediates age-dependent decreases of hippocampal stem cell activity. Cell Stem Cell 28, 967–977.e968 (2021).
Google Scholar
Miller, K. N. et al. Cytoplasmic DNA: sources, sensing, and role in aging and disease. Cell 184, 5506–5526 (2021).
Google Scholar
Wang, Y. et al. Cytoplasmic DNA sensing by KU complex in aged CD4(+) T cell potentiates T cell activation and aging-related autoimmune inflammation. Immunity 54, 632–647.e639 (2021).
Google Scholar
Zhao, J., Wang, J., Chen, D. J., Peterson, S. R. & Trewhella, J. The solution structure of the DNA double-stranded break repair protein Ku and its complex with DNA: a neutron contrast variation study. Biochemistry 38, 2152–2159 (1999).
Google Scholar
Fagundes, N. J. R., Bisso-Machado, R., Figueiredo, P., Varal, M. & Zani, A. L. S. What we talk about when we talk about “Junk DNA”. Genome Biol. Evol. 14, evac055 (2022).
Xu, T. et al. Polymorphic tandem DNA repeats activate the human telomerase reverse transcriptase gene. Proc. Natl Acad. Sci. USA 118, e2019043118 (2021).
Zhu, Y., Liu, X., Ding, X., Wang, F. & Geng, X. Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction. Biogerontology 20, 1–16 (2019).
Google Scholar
Laberthonniere, C., Magdinier, F. & Robin, J. D. Bring it to an end: does telomeres size matter? Cells 8, 30 (2019).
Frenck, R. W. Jr., Blackburn, E. H. & Shannon, K. M. The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl Acad. Sci. USA 95, 5607–5610 (1998).
Google Scholar
Zeichner, S. L. et al. Rapid telomere shortening in children. Blood 93, 2824–2830 (1999).
Google Scholar
Takubo, K. et al. Telomere shortening with aging in human liver. J. Gerontol. A Biol. Sci. Med. Sci. 55, B533–B536 (2000).
Google Scholar
Howard, J. T. et al. Telomere shortening and accelerated aging in US Military Veterans. Int. J. Environ. Res. Public Health 18, 1743 (2021).
Cordoba-Lanus, E. et al. Telomere shortening and accelerated aging in COPD: findings from the BODE cohort. Respir. Res. 18, 59 (2017).
Google Scholar
Turner, K. J., Vasu, V. & Griffin, D. K. Telomere biology and human phenotype. Cells 8, 73 (2019).
Blackburn, E. H., Epel, E. S. & Lin, J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science 350, 1193–1198 (2015).
Google Scholar
Sun, L. et al. Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts. Proc. Natl Acad. Sci. USA 116, 18983–18993 (2019).
Google Scholar
Mojiri, A. et al. Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice. Eur. Heart J. 42, 4352–4369 (2021).
Google Scholar
Ningarhari, M. et al. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target. J. Hepatol. 74, 1155–1166 (2021).
Google Scholar
Cen, J. et al. Anti-aging effect of estrogen on telomerase activity in ovariectomised rats-animal model for menopause. Gynecol. Endocrinol. 31, 582–585 (2015).
Google Scholar
Chakravarti, D., LaBella, K. A. & DePinho, R. A. Telomeres: history, health, and hallmarks of aging. Cell 184, 306–322 (2021).
Google Scholar
Sen, P., Shah, P. P., Nativio, R. & Berger, S. L. Epigenetic mechanisms of longevity and aging. Cell 166, 822–839 (2016).
Google Scholar
Lopez, V., Fernandez, A. F. & Fraga, M. F. The role of 5-hydroxymethylcytosine in development, aging and age-related diseases. Ageing Res. Rev. 37, 28–38 (2017).
Google Scholar
Zarakowska, E. et al. Oxidation products of 5-methylcytosine are decreased in senescent cells and tissues of progeroid mice. J. Gerontol. A Biol. Sci. Med. Sci. 73, 1003–1009 (2018).
Google Scholar
Cagan, A. et al. Somatic mutation rates scale with lifespan across mammals. Nature 604, 517–524 (2022).
Google Scholar
Mendelsohn, A. R. & Larrick, J. W. Epigenetic drift is a determinant of mammalian lifespan. Rejuvenation Res. 20, 430–436 (2017).
Google Scholar
Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).
Google Scholar
Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10, 573–591 (2018).
Google Scholar
Shireby, G. L. et al. Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex. Brain 143, 3763–3775 (2020).
Google Scholar
Loomba, R. et al. DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. JCI Insight 3, e96685 (2018).
Fiorito, G. et al. DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study. Aging Cell 20, e13439 (2021).
Google Scholar
Demidenko, O. et al. Rejuvant(R), a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test. Aging 13, 24485–24499 (2021).
Google Scholar
Belsky, D. W. et al. Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm. eLife 9, e54870 (2020).
Paluvai, H., Di Giorgio, E. & Brancolini, C. The histone code of senescence. Cells 9, 466 (2020).
Yi, S. J. & Kim, K. New insights into the role of histone changes in aging. Int. J. Mol. Sci. 21, 8241 (2020).
Padeken, J., Methot, S. P. & Gasser, S. M. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nat. Rev. Mol. Cell Biol. 23, 623–640 (2022).
Google Scholar
Wang, Y., Yuan, Q. & Xie, L. Histone modifications in aging: the underlying mechanisms and implications. Curr. Stem Cell Res. Ther. 13, 125–135 (2018).
Google Scholar
Zhang, W. et al. Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging. Science 348, 1160–1163 (2015).
Google Scholar
Kirfel, P., Vilcinskas, A. & Skaljac, M. Lysine acetyltransferase p300/CBP plays an important role in reproduction, embryogenesis and longevity of the pea aphid Acyrthosiphon pisum. Insects 11, 265 (2020).
Kane, A. E. & Sinclair, D. A. Epigenetic changes during aging and their reprogramming potential. Crit. Rev. Biochem. Mol. Biol. 54, 61–83 (2019).
Google Scholar
Zhu, D. et al. NuRD mediates mitochondrial stress-induced longevity via chromatin remodeling in response to acetyl-CoA level. Sci. Adv. 6, eabb2529 (2020).
Google Scholar
Liu, Z. et al. Large-scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging. Dev. Cell 57, 1347–1368.e1312 (2022).
Google Scholar
Liu, X., Li, M., Xia, X., Li, X. & Chen, Z. Mechanism of chromatin remodelling revealed by the Snf2-nucleosome structure. Nature 544, 440–445 (2017).
Google Scholar
Coux, R. X., Owens, N. D. L. & Navarro, P. Chromatin accessibility and transcription factor binding through the perspective of mitosis. Transcription 11, 236–240 (2020).
Google Scholar
Zhang, C. et al. ATF3 drives senescence by reconstructing accessible chromatin profiles. Aging Cell 20, e13315 (2021).
Google Scholar
Wu, Q., Li, B., Liu, L., Sun, S. & Sun, S. Centrosome dysfunction: a link between senescence and tumor immunity. Signal Transduct. Target Ther. 5, 107 (2020).
Google Scholar
Jackson-Cook, C. Constitutional and acquired autosomal aneuploidy. Clin. Lab Med. 31, 481–511 (2011).
Google Scholar
Martin, J. M., Kellett, J. M. & Kahn, J. Aneuploidy in cultured human lymphocytes: I. Age and sex differences. Age Ageing 9, 147–153 (1980).
Google Scholar
Nowinski, G. P. et al. The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. Am. J. Hum. Genet. 46, 1101–1111 (1990).
Google Scholar
Azzalin, C. M. & Lingner, J. Cell biology. Telomere wedding ends in divorce. Science. 304, 60–62 (2004).
Dynek, J. N. & Smith, S. Resolution of sister telomere association is required for progression through mitosis. Science 304, 97–100 (2004).
Google Scholar
Arendt, T., Ueberham, U. & Janitz, M. Non-coding transcriptome in brain aging. Aging 9, 1943–1944 (2017).
Google Scholar
Wang, L. et al. PEGylated reduced-graphene oxide hybridized with Fe3O4 nanoparticles for cancer photothermal-immunotherapy. J. Mater. Chem. B 7, 7406–7414 (2019).
Google Scholar
Nicholson, A. W. Structure, reactivity, and biology of double-stranded RNA. Prog. Nucleic Acid Res. Mol. Biol. 52, 1–65 (1996).
Google Scholar
Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847–859 (2012).
Google Scholar
Saldi, T. K., Gonzales, P. K., LaRocca, T. J. & Link, C. D. Neurodegeneration, heterochromatin, and double-stranded RNA. J. Exp. Neurosci. 13, 1179069519830697 (2019).
Google Scholar
Zhang, Y. et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature 548, 52–57 (2017).
Google Scholar
Idda, M. L., Munk, R., Abdelmohsen, K. & Gorospe, M. Noncoding RNAs in Alzheimer’s disease. Wiley Interdiscip. Rev. RNA 9, 10.1002/wrna.1463 (2018).
Knupp, D. & Miura, P. CircRNA accumulation: a new hallmark of aging? Mech. Ageing Dev. 173, 71–79 (2018).
Google Scholar
Hipp, M. S., Kasturi, P. & Hartl, F. U. The proteostasis network and its decline in ageing. Nat. Rev. Mol. Cell Biol. 20, 421–435 (2019).
Google Scholar
Sabath, N. et al. Cellular proteostasis decline in human senescence. Proc. Natl Acad. Sci. USA 117, 31902–31913 (2020).
Google Scholar
Li, Y. et al. A mitochondrial FUNDC1/HSC70 interaction organizes the proteostatic stress response at the risk of cell morbidity. EMBO J. 38, e98786 (2019).
Koyuncu, S. et al. Rewiring of the ubiquitinated proteome determines ageing in C. elegans. Nature 596, 285–290 (2021).
Google Scholar
Zhou, D., Borsa, M. & Simon, A. K. Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells. Aging Cell 20, e13316 (2021).
Google Scholar
Zhao, Q. et al. Activating transcription factor 3 involved in Pseudomonas aeruginosa PAO1-induced macrophage senescence. Mol. Immunol. 133, 122–127 (2021).
Google Scholar
Sun, Y. et al. Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells. Sci. Adv. 7, eabj6877 (2021).
Google Scholar
Timmer, L. T., Hoogaars, W. M. H. & Jaspers, R. T. The role of IGF-1 signaling in skeletal muscle atrophy. Adv. Exp. Med. Biol. 1088, 109–137 (2018).
Google Scholar
Ock, S. et al. Deletion of IGF-1 receptors in cardiomyocytes attenuates cardiac aging in male mice. Endocrinology 157, 336–345 (2016).
Google Scholar
Gong, Z. et al. Reductions in serum IGF-1 during aging impair health span. Aging Cell 13, 408–418 (2014).
Google Scholar
Ascenzi, F. et al. Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell 18, e12954 (2019).
Google Scholar
Yoshida, T. & Delafontaine, P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells 9, 1970 (2020).
Templeman, N. M. & Murphy, C. T. Regulation of reproduction and longevity by nutrient-sensing pathways. J. Cell Biol. 217, 93–106 (2018).
Google Scholar
Gao, K., Li, Y., Hu, S. & Liu, Y. SUMO peptidase ULP-4 regulates mitochondrial UPR-mediated innate immunity and lifespan extension. eLife 8, e41792 (2019).
Princz, A. & Tavernarakis, N. SUMOylation in neurodegenerative diseases. Gerontology 66, 122–130 (2020).
Google Scholar
Gong, L., Sun, Q. & Li, D. W. Sumoylation in cellular senescence and aging. Curr. Mol. Med. 16, 871–876 (2017).
Google Scholar
Larrick, J. W., Larrick, J. W. & Mendelsohn, A. R. SUMO wrestles with mitophagy to extend lifespan. Rejuvenation Res. 23, 527–532 (2020).
Google Scholar
Stein, K. C., Morales-Polanco, F., van der Lienden, J., Rainbolt, T. K. & Frydman, J. Ageing exacerbates ribosome pausing to disrupt cotranslational proteostasis. Nature 601, 637–642 (2022).
Google Scholar
Fernandez, A. F. et al. Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature 558, 136–140 (2018).
Google Scholar
Kitada, M. & Koya, D. Autophagy in metabolic disease and ageing. Nat. Rev. Endocrinol. 17, 647–661 (2021).
Google Scholar
Hansen, M., Rubinsztein, D. C. & Walker, D. W. Autophagy as a promoter of longevity: insights from model organisms. Nat. Rev. Mol. Cell Biol. 19, 579–593 (2018).
Google Scholar
Leidal, A. M., Levine, B. & Debnath, J. Autophagy and the cell biology of age-related disease. Nat. Cell Biol. 20, 1338–1348 (2018).
Google Scholar
Zeidan, R. S., Han, S. M., Leeuwenburgh, C. & Xiao, R. Iron homeostasis and organismal aging. Ageing Res Rev. 72, 101510 (2021).
Google Scholar
Guo, H. et al. Induction of autophagy via the ROS-dependent AMPK-mTOR pathway protects copper-induced spermatogenesis disorder. Redox Biol. 49, 102227 (2022).
Google Scholar
Tang, D. & Kroemer, G. Ferroptosis. Curr. Biol. 30, R1292–R1297 (2020).
Aman, Y., Cao, S. & Fang, E. F. Iron out, mitophagy in! A way to slow down hepatocellular carcinoma. EMBO Rep. 21, e51652 (2020).
Google Scholar
Pushkar, Y. et al. Aging results in copper accumulations in glial fibrillary acidic protein-positive cells in the subventricular zone. Aging Cell 12, 823–832 (2013).
Google Scholar
Masaldan, S. et al. Copper accumulation in senescent cells: Interplay between copper transporters and impaired autophagy. Redox Biol. 16, 322–331 (2018).
Google Scholar
Fakouri, N. B. et al. Toward understanding genomic instability, mitochondrial dysfunction and aging. FEBS J. 286, 1058–1073 (2019).
Google Scholar
Fouquerel, E. et al. Targeted and persistent 8-oxoguanine base damage at telomeres promotes telomere loss and crisis. Mol. Cell 75, 117–130.e116 (2019).
Google Scholar
Meng, J., Lv, Z., Wang, Y. & Chen, C. Identification of the redox-stress signaling threshold (RST): increased RST helps to delay aging in C. elegans. Free Radic. Biol. Med. 178, 54–58 (2022).
Google Scholar
Vyssokikh, M. Y. et al. Mild depolarization of the inner mitochondrial membrane is a crucial component of an anti-aging program. Proc. Natl Acad. Sci. USA 117, 6491–6501 (2020).
Google Scholar
Ristow, M. Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits. Nat. Med. 20, 709–711 (2014).
Google Scholar
Schieber, M. & Chandel, N. S. ROS function in redox signaling and oxidative stress. Curr. Biol. 24, R453–R462 (2014).
Google Scholar
Xiao, H. et al. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell 180, 968–983 e924 (2020).
Google Scholar
Smith, A. L. et al. Age-associated mitochondrial DNA mutations cause metabolic remodelling that contributes to accelerated intestinal tumorigenesis. Nat. Cancer 1, 976–989 (2020).
Google Scholar
Singh, B., Schoeb, T. R., Bajpai, P., Slominski, A. & Singh, K. K. Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function. Cell Death Dis. 9, 735 (2018).
Google Scholar
Fang, E. F. et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat. Rev. Mol. Cell Biol. 17, 308–321 (2016).
Google Scholar
Reiten, O. K., Wilvang, M. A., Mitchell, S. J., Hu, Z. & Fang, E. F. Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing. Mech. Ageing Dev. 199, 111567 (2021).
Google Scholar
Scheibye-Knudsen, M. et al. A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in cockayne syndrome. Cell Metab. 20, 840–855 (2014).
Google Scholar
Fang, E. F. et al. NAD(+) replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab. 24, 566–581 (2016).
Google Scholar
Verdin, E. NAD(+) in aging, metabolism, and neurodegeneration. Science 350, 1208–1213 (2015).
Google Scholar
Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat. Metab. 3, 1290–1301 (2021).
Google Scholar
Dollerup, O. L. et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am. J. Clin. Nutr. 108, 343–353 (2018).
Google Scholar
Dollerup, O. L. et al. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. J. Physiol. 598, 731–754 (2020).
Google Scholar
Remie, C. M. E. et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am. J. Clin. Nutr. 112, 413–426 (2020).
Google Scholar
Popov, L. D. Mitochondrial biogenesis: an update. J. Cell Mol. Med 24, 4892–4899 (2020).
Google Scholar
Onishi, M., Yamano, K., Sato, M., Matsuda, N. & Okamoto, K. Molecular mechanisms and physiological functions of mitophagy. EMBO J. 40, e104705 (2021).
Google Scholar
Konig, T. et al. MIROs and DRP1 drive mitochondrial-derived vesicle biogenesis and promote quality control. Nat. Cell Biol. 23, 1271–1286 (2021).
Google Scholar
Ryan, T. A. & Tumbarello, D. A. A central role for mitochondrial-derived vesicles in the innate immune response: implications for Parkinson’s disease. Neural Regen. Res. 16, 1779–1780 (2021).
Google Scholar
Rhinn, M., Ritschka, B. & Keyes, W. M. Cellular senescence in development, regeneration and disease. Development 146, dev151837 (2019).
Kowald, A., Passos, J. F. & Kirkwood, T. B. L. On the evolution of cellular senescence. Aging Cell 19, e13270 (2020).
Google Scholar
Birch, J. & Gil, J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 34, 1565–1576 (2020).
Google Scholar
Palmer, A. K., Gustafson, B., Kirkland, J. L. & Smith, U. Cellular senescence: at the nexus between ageing and diabetes. Diabetologia 62, 1835–1841 (2019).
Google Scholar
Cai, Y. et al. The landscape of aging. Sci. China Life Sci. 1–101 (2022).
Iram, T. et al. Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17. Nature 605, 509–515 (2022).
Google Scholar
Prieto, L. I. & Baker, D. J. Cellular senescence and the immune system in cancer. Gerontology 65, 505–512 (2019).
Google Scholar
Mittelbrunn, M. & Kroemer, G. Hallmarks of T cell aging. Nat. Immunol. 22, 687–698 (2021).
Google Scholar
Desdin-Mico, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371–1376 (2020).
Google Scholar
Deng, P. et al. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell 28, 1057–1073.e1057 (2021).
Google Scholar
Revuelta, M. & Matheu, A. Autophagy in stem cell aging. Aging Cell 16, 912–915 (2017).
Google Scholar
Zhang, D. et al. Autophagy inhibits the mesenchymal stem cell aging induced by D-galactose through ROS/JNK/p38 signalling. Clin. Exp. Pharm. Physiol. 47, 466–477 (2020).
Google Scholar
Ho, T. T. et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature 543, 205–210 (2017).
Google Scholar
Rodriguez-Ramirez, C. & Nor, J. E. p53 and cell fate: sensitizing head and neck cancer stem cells to chemotherapy. Crit. Rev. Oncog. 23, 173–187 (2018).
Google Scholar
Manzano-Lopez, J. & Monje-Casas, F. Asymmetric cell division and replicative aging: a new perspective from the spindle poles. Curr. Genet. 66, 719–727 (2020).
Google Scholar
Daynac, M. & Petritsch, C. K. Regulation of asymmetric cell division in mammalian neural stem and cancer precursor cells. Results Probl. Cell Differ. 61, 375–399 (2017).
Google Scholar
Borsa, M. et al. Asymmetric cell division shapes naive and virtual memory T-cell immunity during ageing. Nat. Commun. 12, 2715 (2021).
Google Scholar
Lengefeld, J. et al. Cell size is a determinant of stem cell potential during aging. Sci. Adv. 7, eabk0271 (2021).
Google Scholar
Fafian-Labora, J. A. & O’Loghlen, A. Classical and nonclassical intercellular communication in senescence and ageing. Trends Cell Biol. 30, 628–639 (2020).
Google Scholar
Xu, Q. et al. The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice. Nat. Metab. 3, 1706–1726 (2021).
Google Scholar
van Niel, G. et al. Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat. Rev. Mol. Cell Biol. 23, 369–382 (2022).
Google Scholar
Kfoury, Y. S. et al. tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic niche. Cell Stem Cell 28, 2090–2103.e2099 (2021).
Google Scholar
Crewe, C. et al. An endothelial-to-adipocyte extracellular vesicle axis governed by metabolic state. Cell 175, 695–708 e613 (2018).
Google Scholar
Narita, M. Juxtacrine regulation of cellular senescence. BMB Rep. 52, 3–4 (2019).
Google Scholar
Hoare, M. et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat. Cell Biol. 18, 979–992 (2016).
Google Scholar
Giordano-Santini, R., Linton, C. & Hilliard, M. A. Cell-cell fusion in the nervous system: alternative mechanisms of development, injury, and repair. Semin Cell Dev. Biol. 60, 146–154 (2016).
Google Scholar
Wang, Y., Welc, S. S., Wehling-Henricks, M. & Tidball, J. G. Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers. Aging Cell 17, e12828 (2018).
Google Scholar
Chaigne, A. & Brunet, T. Incomplete abscission and cytoplasmic bridges in the evolution of eukaryotic multicellularity. Curr. Biol. 32, R385–R397 (2022).
Google Scholar
Walters, H. E. & Cox, L. S. Intercellular transfer of mitochondria between senescent cells through cytoskeleton-supported intercellular bridges requires mTOR and CDC42 signalling. Oxid. Med. Cell Longev. 2021, 6697861 (2021).
Google Scholar
Ma, S. et al. Caloric restriction reprograms the single-cell transcriptional landscape of Rattus norvegicus aging. Cell 180, 984–1001.e1022 (2020).
Google Scholar
Schaum, N. et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature 583, 596–602 (2020).
Google Scholar
Shannon, O. M. et al. Mediterranean diet and the hallmarks of ageing. Eur. J. Clin. Nutr. 75, 1176–1192 (2021).
Google Scholar
Gonzalez, A. & Hall, M. N. Nutrient sensing and TOR signaling in yeast and mammals. EMBO J. 36, 397–408 (2017).
Google Scholar
Lin, S. C. & Hardie, D. G. AMPK: sensing glucose as well as cellular energy status. Cell Metab. 27, 299–313 (2018).
Google Scholar
Gonzalez, A., Hall, M. N., Lin, S. C. & Hardie, D. G. AMPK and TOR: the Yin and Yang of cellular nutrient sensing and growth control. Cell Metab. 31, 472–492 (2020).
Google Scholar
Fernandes, S. A. & Demetriades, C. The multifaceted role of nutrient sensing and mTORC1 signaling in physiology and aging. Front. Aging 2, 707372 (2021).
Google Scholar
Johnson, S. C. Nutrient sensing, signaling and ageing: the role of IGF-1 and mTOR in ageing and age-related disease. Subcell. Biochem. 90, 49–97 (2018).
Google Scholar
Kowalski, K. & Mulak, A. Brain-gut-microbiota axis in Alzheimer’s disease. J. Neurogastroenterol. Motil. 25, 48–60 (2019).
Google Scholar
Wilmanski, T. et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat. Metab. 3, 274–286 (2021).
Google Scholar
Kim, S. & Jazwinski, S. M. The gut microbiota and healthy aging: a mini-review. Gerontology 64, 513–520 (2018).
Google Scholar
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576–590 (2018).
Google Scholar
Wang, G. et al. Bridging intestinal immunity and gut microbiota by metabolites. Cell Mol. Life Sci. 76, 3917–3937 (2019).
Google Scholar
Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877–2013 (2019).
Google Scholar
Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965–977 (2015).
Google Scholar
Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).
Google Scholar
Jeppesen, D. K., Bohr, V. A. & Stevnsner, T. DNA repair deficiency in neurodegeneration. Prog. Neurobiol. 94, 166–200 (2011).
Google Scholar
Scheibye-Knudsen, M. Neurodegeneration in accelerated aging. Dan. Med. J. 63, B5308 (2016).
Leandro, G. S., Sykora, P. & Bohr, V. A. The impact of base excision DNA repair in age-related neurodegenerative diseases. Mutat. Res. 776, 31–39 (2015).
Google Scholar
Fielder, E., von Zglinicki, T. & Jurk, D. The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state? J. Alzheimers Dis. 60, S107–s131 (2017).
Google Scholar
Gao, X. et al. Epigenetics in Alzheimer’s disease. Front. Aging Neurosci. 14, 911635 (2022).
Google Scholar
De Jager, P. L., Srivastava, G., Lunnon, K., Burgess, J. & Schalkwyk, L. C. Alzheimer’s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat. Neurosci. 17, 1156–1163 (2014).
Google Scholar
Ashrafian, H., Zadeh, E. H. & Khan, R. H. Review on Alzheimer’s disease: inhibition of amyloid beta and tau tangle formation. Int. J. Biol. Macromol. 167, 382–394 (2021).
Google Scholar
Nisbet, R. M. & Götz, J. Amyloid-β and Tau in Alzheimer’s disease: novel pathomechanisms and non-pharmacological treatment strategies. J. Alzheimers Dis. 64, S517–s527 (2018).
Google Scholar
Tong, B. C., Wu, A. J., Li, M. & Cheung, K. H. Calcium signaling in Alzheimer’s disease & therapies. Biochim. Biophys. Acta Mol. Cell Res. 1865, 1745–1760 (2018).
Google Scholar
Haass, C. & Selkoe, D. If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? PLoS Biol. 20, e3001694 (2022).
Google Scholar
Lee, J. H. et al. Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques. Nat. Neurosci. 25, 688–701 (2022).
Google Scholar
Biundo, F. et al. Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations. Transl. Psychiatry 7, e1198 (2017).
Google Scholar
Roy, D. S. et al. Memory retrieval by activating engram cells in mouse models of early Alzheimer’s disease. Nature 531, 508–512 (2016).
Google Scholar
Perez Ortiz, J. M. & Swerdlow, R. H. Mitochondrial dysfunction in Alzheimer’s disease: role in pathogenesis and novel therapeutic opportunities. Br. J. Pharm. 176, 3489–3507 (2019).
Google Scholar
Fang, E. F. et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat. Neurosci. 22, 401–412 (2019).
Google Scholar
Miller, S. & Muqit, M. M. K. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson’s disease. Neurosci. Lett. 705, 7–13 (2019).
Google Scholar
Li, N., Shu, J., Yang, X., Wei, W. & Yan, A. Exosomes derived from M2 microglia cells attenuates neuronal impairment and mitochondrial dysfunction in Alzheimer’s disease through the PINK1/Parkin pathway. Front. Cell Neurosci. 16, 874102 (2022).
Google Scholar
Gaikwad, S. et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia. Cell Rep. 36, 109419 (2021).
Google Scholar
Han, X., Zhang, T., Liu, H., Mi, Y. & Gou, X. Astrocyte senescence and Alzheimer’s disease: a review. Front. Aging Neurosci. 12, 148 (2020).
Google Scholar
Zhong, Y. et al. A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson’s disease. NPJ Parkinsons Dis. 8, 82 (2022).
Google Scholar
Shahnawaz, M. et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy. Nature 578, 273–277 (2020).
Google Scholar
Guo, W. et al. Association of LAG3 genetic variation with an increased risk of PD in Chinese female population. J. Neuroinflammation 16, 270 (2019).
Google Scholar
Polymeropoulos, M. H. Revisiting the history of the 1997 alpha-synuclein discovery in Parkinson’s disease. J. Parkinsons Dis. 9, 443–444 (2019).
Google Scholar
Blauwendraat, C. et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia. Brain 143, 234–248 (2020).
Google Scholar
Sengupta, U. & Kayed, R. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. Prog. Neurobiol. 214, 102270 (2022).
Google Scholar
Rocha, E. M., De Miranda, B. & Sanders, L. H. Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurobiol. Dis. 109, 249–257 (2018).
Google Scholar
Savarese, G. et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc. Res. cvac013 (2022).
Chen, K. et al. Klotho deficiency causes heart aging via impairing the Nrf2-GR pathway. Circ. Res. 128, 492–507 (2021).
Google Scholar
Anderson, R. et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J. 38, e100492 (2019).
Tang, X., Li, P. H. & Chen, H. Z. Cardiomyocyte senescence and cellular communications within myocardial microenvironments. Front. Endocrinol. 11, 280 (2020).
Google Scholar
Chen, M. S., Lee, R. T. & Garbern, J. C. Senescence mechanisms and targets in the heart. Cardiovasc. Res. 118, 1173–1187 (2022).
Google Scholar
Weissman, D. & Maack, C. Redox signaling in heart failure and therapeutic implications. Free Radic. Biol. Med. 171, 345–364 (2021).
Google Scholar
Kowalczyk, P. et al. Mitochondrial oxidative stress-A causative factor and therapeutic target in many diseases. Int. J. Mol. Sci. 22, 13384 (2021).
Martini, H. et al. Selective cardiomyocyte oxidative stress leads to bystander senescence of cardiac stromal cells. Int. J. Mol. Sci. 22, 2245 (2021).
Zhang, X. et al. MicroRNA-195 regulates metabolism in failing myocardium via alterations in sirtuin 3 expression and mitochondrial protein acetylation. Circulation 137, 2052–2067 (2018).
Google Scholar
Gu, J. et al. Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis. Cell Death Dis. 9, 82 (2018).
Google Scholar
El-Nachef, D. et al. Repressive histone methylation regulates cardiac myocyte cell cycle exit. J. Mol. Cell Cardiol. 121, 1–12 (2018).
Google Scholar
Berulava, T. et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur. J. Heart Fail. 22, 54–66 (2020).
Google Scholar
Chen, Y. et al. Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway. Cell Death Dis. 13, 276 (2022).
Google Scholar
Katsuumi, G., Shimizu, I., Yoshida, Y. & Minamino, T. Vascular senescence in cardiovascular and metabolic diseases. Front. Cardiovasc. Med. 5, 18 (2018).
Google Scholar
Gevaert, A. B. et al. Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model. Circ. Heart Fail. 10, e003806 (2017).
Jesel, L. et al. Atrial fibrillation progression is associated with cell senescence burden as determined by p53 and p16 expression. J. Clin. Med. 9, 36 (2019).
Sung, J. Y., Kim, S. G., Kim, J. R. & Choi, H. C. Prednisolone suppresses adriamycin-induced vascular smooth muscle cell senescence and inflammatory response via the SIRT1-AMPK signaling pathway. PLoS ONE 15, e0239976 (2020).
Google Scholar
Xia, W., Chen, H., Xie, C. & Hou, M. Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a. Aging 12, 8241–8260 (2020).
Google Scholar
Jia, G., Aroor, A. R., Jia, C. & Sowers, J. R. Endothelial cell senescence in aging-related vascular dysfunction. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 1802–1809 (2019).
Google Scholar
Howden, R. Nrf2 and cardiovascular defense. Oxid. Med. Cell Longev. 2013, 104308 (2013).
Google Scholar
Xiao, X. et al. Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src. Signal Transduct. Target Ther. 6, 354 (2021).
Google Scholar
de Yebenes, V. G. et al. Aging-associated miR-217 aggravates atherosclerosis and promotes cardiovascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 40, 2408–2424 (2020).
Google Scholar
Menghini, R. et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120, 1524–1532 (2009).
Google Scholar
Schiro, A. et al. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis 234, 295–302 (2014).
Google Scholar
Takahashi, T. & Kubo, H. The role of microparticles in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 303–314 (2014).
Kugel, S. & Mostoslavsky, R. Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem. Sci. 39, 72–81 (2014).
Google Scholar
Guarente, L. Franklin H. Epstein lecture: sirtuins, aging, and medicine. N. Engl. J. Med. 364, 2235–2244 (2011).
Google Scholar
Artal-Sanz, M. & Tavernarakis, N. Prohibitin and mitochondrial biology. Trends Endocrinol. Metab. 20, 394–401 (2009).
Google Scholar
Schleicher, M. et al. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J. Cell Biol. 180, 101–112 (2008).
Google Scholar
Dermaku-Sopjani, M., Kolgeci, S., Abazi, S. & Sopjani, M. Significance of the anti-aging protein Klotho. Mol. Membr. Biol. 30, 369–385 (2013).
Google Scholar
Wang, J. C. & Bennett, M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 111, 245–259 (2012).
Google Scholar
Brozovich, F. V. et al. Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharm. Rev. 68, 476–532 (2016).
Google Scholar
Matthews, C. et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99, 156–164 (2006).
Google Scholar
Liu, Y., Drozdov, I., Shroff, R., Beltran, L. E. & Shanahan, C. M. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ. Res. 112, e99–e109 (2013).
Google Scholar
Grootaert, M. O. J., Finigan, A., Figg, N. L., Uryga, A. K. & Bennett, M. R. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ. Res. 128, 474–491 (2021).
Google Scholar
Gosling, J. et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103, 773–778 (1999).
Google Scholar
Song, Y. et al. Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 32, 103–109 (2012).
Google Scholar
Gardner, S. E., Humphry, M., Bennett, M. R. & Clarke, M. C. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 1963–1974 (2015).
Google Scholar
Hamczyk, M. R. & Andres, V. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome. Nucleus 10, 28–34 (2019).
Google Scholar
Potekhina, A. V. et al. Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis. Atherosclerosis 238, 17–21 (2015).
Google Scholar
Fadini, G. P., Losordo, D. & Dimmeler, S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ. Res. 110, 624–637 (2012).
Google Scholar
Lee, P. S. & Poh, K. K. Endothelial progenitor cells in cardiovascular diseases. World J. Stem Cells 6, 355–366 (2014).
Google Scholar
Yiu, K. H. & Tse, H. F. Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function. Arterioscler. Thromb. Vasc. Biol. 34, 1136–1143 (2014).
Google Scholar
Kalyani, R. R., Golden, S. H. & Cefalu, W. T. Diabetes and aging: unique considerations and goals of care. Diabetes Care 40, 440–443 (2017).
Google Scholar
Khan, R. M. M. et al. From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina 55, 546 (2019).
Lytrivi, M., Castell, A. L., Poitout, V. & Cnop, M. Recent insights into mechanisms of beta-cell lipo- and glucolipotoxicity in type 2 diabetes. J. Mol. Biol. 432, 1514–1534 (2020).
Google Scholar
de Zegher, F., Diaz, M. & Ibanez, L. Association between long telomere length and insulin sensitization in adolescent girls with hyperinsulinemic androgen excess. JAMA Pediatr. 169, 787–788 (2015).
Google Scholar
Tamura, Y. et al. beta-cell telomere attrition in diabetes: inverse correlation between HbA1c and telomere length. J. Clin. Endocrinol. Metab. 99, 2771–2777 (2014).
Google Scholar
Guo, N. et al. Short telomeres compromise beta-cell signaling and survival. PLoS ONE 6, e17858 (2011).
Google Scholar
Tamura, Y., Takubo, K., Aida, J., Araki, A. & Ito, H. Telomere attrition and diabetes mellitus. Geriatr. Gerontol. Int. 16, 66–74 (2016).
Google Scholar
Fonseca, S. G., Gromada, J. & Urano, F. Endoplasmic reticulum stress and pancreatic beta-cell death. Trends Endocrinol. Metab. 22, 266–274 (2011).
Google Scholar
Zhang, I. X., Raghavan, M. & Satin, L. S. The endoplasmic reticulum and calcium homeostasis in pancreatic beta cells. Endocrinology 161, bqz028 (2020).
Fontana, L., Nehme, J. & Demaria, M. Caloric restriction and cellular senescence. Mech. Ageing Dev. 176, 19–23 (2018).
Google Scholar
Eguchi, K. et al. Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab. 15, 518–533 (2012).
Google Scholar
Maedler, K. et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 127, 1589 (2017).
Google Scholar
Chan, J. Y., Lee, K., Maxwell, E. L., Liang, C. & Laybutt, D. R. Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes. Diabetologia 62, 993–999 (2019).
Google Scholar
Ehses, J. A. et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56, 2356–2370 (2007).
Google Scholar
Sone, H. & Kagawa, Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48, 58–67 (2005).
Google Scholar
Aguayo-Mazzucato, C. et al. Acceleration of beta cell aging determines diabetes and senolysis improves disease outcomes. Cell Metab. 30, 129–142.e124 (2019).
Google Scholar
Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232–236 (2011).
Google Scholar
Midha, A. et al. Unique human and mouse beta-cell senescence-associated secretory phenotype (SASP) reveal conserved signaling pathways and heterogeneous factors. Diabetes 70, 1098–1116 (2021).
Google Scholar
Liu, Z., Wu, K. K. L., Jiang, X., Xu, A. & Cheng, K. K. Y. The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders. Clin. Sci. 134, 315–330 (2020).
Google Scholar
Iatcu, C. O., Steen, A. & Covasa, M. Gut microbiota and complications of type-2 diabetes. Nutrients 14, 166 (2021).
Gan, L., Chitturi, S. & Farrell, G. C. Mechanisms and implications of age-related changes in the liver: nonalcoholic fatty liver disease in the elderly. Curr. Gerontol. Geriatr. Res. 2011, 1–12 (2011).
Google Scholar
Alqahtani, S. A. & Schattenberg, J. M. NAFLD in the elderly. Clin. Inter. Aging 16, 1633–1649 (2021).
Google Scholar
Aravinthan, A. et al. Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease. Cell Cycle 13, 1489–1494 (2014).
Google Scholar
Palma, R. et al. The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications. J. Clin. Med. 11, 3649 (2022).
Google Scholar
Kim, J.-H., Jung, D. Y., Nagappan, A. & Jung, M. H. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2. Sci. Rep. 8, 13734 (2018).
Rector, R. S. et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J. Hepatol. 52, 727–736 (2010).
Google Scholar
Hunt, N. J., Kang, S. W., Lockwood, G. P., Le Couteur, D. G. & Cogger, V. C. Hallmarks of aging in the liver. Comput. Struct. Biotechnol. J. 17, 1151–1161 (2019).
Google Scholar
Ramanathan, R., Ali, A. H. & Ibdah, J. A. Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease. Int. J. Mol. Sci. 23, 7280 (2022).
Google Scholar
Ipsen, D. H., Lykkesfeldt, J. & Tveden-Nyborg, P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol. Life Sci. 75, 3313–3327 (2018).
Google Scholar
Reinecke, F., Smeitink, J. A. M. & van der Westhuizen, F. H. OXPHOS gene expression and control in mitochondrial disorders. Biochim. Biophys. Acta 1792, 1113–1121 (2009).
Google Scholar
Dabravolski, S. A., Bezsonov, E. E. & Orekhov, A. N. The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression. Biomed. Pharmacother. 142, 112041 (2021).
Google Scholar
Han, X. et al. Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice. PeerJ 7, e7568 (2019).
Google Scholar
Li, D.-J. et al. NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin. Theranostics 11, 4381–4402 (2021).
Google Scholar
Zhou, C.-C. et al. Hepatic NAD+deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. Br. J. Pharm. 173, 2352–2368 (2016).
Google Scholar
Bozaykut, P., Sahin, A., Karademir, B. & Ozer, N. K. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis. Mech. Ageing Dev. 157, 17–29 (2016).
Google Scholar
Volmer, R., van der Ploeg, K. & Ron, D. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proc. Natl Acad. Sci. USA 110, 4628–4633 (2013).
Google Scholar
Lebeaupin, C. et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 69, 927–947 (2018).
Google Scholar
Dasgupta, D. et al. IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis. Gastroenterology 159, 1487–1503.e1417 (2020).
Google Scholar
Kern, P. et al. Creld2 function during unfolded protein response is essential for liver metabolism homeostasis. FASEB J. 35, e21939 (2021).
Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131–1135 (2009).
Google Scholar
Carotti, S. et al. Lipophagy impairment is associated with disease progression in NAFLD. Front. Physiol. 11, 850 (2020).
Ferrara-Romeo, I. et al. The mTOR pathway is necessary for survival of mice with short telomeres. Nat. Commun. 11, 1168 (2020).
Google Scholar
Gong, Z., Tas, E., Yakar, S. & Muzumdar, R. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol. Cell Endocrinol. 455, 115–130 (2017).
Google Scholar
Amir, M. & Czaja, M. J. Autophagy in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 5, 159–166 (2014).
Google Scholar
Ogrodnik, M. et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 8, 15691 (2017).
Zhang, J. et al. The p66shc-mediated regulation of hepatocyte senescence influences hepatic steatosis in nonalcoholic fatty liver disease. Med. Sci. Monit. 26, e921887 (2020).
Jin, J. et al. Activation of CDK4 triggers development of non-alcoholic fatty liver disease. Cell Rep. 16, 744–756 (2016).
Google Scholar
Nguyen, P. et al. Elimination of age-associated hepatic steatosis and correction of aging phenotype by inhibition of cdk4-C/EBPα-p300 axis. Cell Rep. 24, 1597–1609 (2018).
Google Scholar
Childs, B. G. et al. Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Disco. 16, 718–735 (2017).
Google Scholar
Ohtani, N. & Hara, E. Gut‐liver axis‐mediated mechanism of liver cancer: a special focus on the role of gut microbiota. Cancer Sci. 112, 4433–4443 (2021).
Google Scholar
Arab, J. P., Arrese, M. & Shah, V. H. Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives. Hepatol. Res. 50, 407–418 (2020).
Google Scholar
Fanta Barrow, S. K. et al. Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling. Hepatology 74, 704–722 (2021).
Google Scholar
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H. & Moshage, H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol. Int. 15, 21–35 (2021).
Google Scholar
Nicklas, B. J. et al. Effects of caloric restriction on cardiorespiratory fitness, fatigue, and disability responses to aerobic exercise in older adults with obesity: a randomized controlled trial. J. Gerontol. A Biol. Sci. Med. Sci. 74, 1084–1090 (2019).
Google Scholar
Linden, A. G. et al. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J. Lipid Res. 59, 475–487 (2018).
Google Scholar
Barazzoni, R., Gortan Cappellari, G., Ragni, M. & Nisoli, E. Insulin resistance in obesity: an overview of fundamental alterations. Eat. Weight Disord. 23, 149–157 (2018).
Google Scholar
Huby, T. & Gautier, E. L. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat. Rev. Immunol. 22, 429–443 (2021).
Google Scholar
Thibaut, R. et al. Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease. FEBS J. 289, 3024–3057 (2021).
Google Scholar
Strnad, P. et al. Kupffer cells undergo fundamental changes during the development of experimental NASH and are critical in initiating liver damage and inflammation. PLos ONE 11, e0159524 (2016).
Google Scholar
Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958–969 (2008).
Google Scholar
Tran, S. et al. Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity 53, 627–640.e625 (2020).
Google Scholar
Remmerie, A. et al. Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver. Immunity 53, 641–657.e614 (2020).
Google Scholar
Seidman, J. S. et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52, 1057–1074.e1057 (2020).
Google Scholar
Takatsu, M. et al. Calorie restriction attenuates cardiac remodeling and diastolic dysfunction in a rat model of metabolic syndrome. Hypertension 62, 957–965 (2013).
Google Scholar
Jeon, O. H., David, N., Campisi, J. & Elisseeff, J. H. Senescent cells and osteoarthritis: a painful connection. J. Clin. Invest. 128, 1229–1237 (2018).
Google Scholar
Wieland, H. A., Michaelis, M., Kirschbaum, B. J. & Rudolphi, K. A. Osteoarthritis – an untreatable disease? Nat. Rev. Drug Disco. 4, 331–344 (2005).
Google Scholar
Barbour, K. E., Helmick, C. G., Boring, M. & Brady, T. J. Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation – United States, 2013-2015. MMWR Morb. Mortal. Wkly. Rep. 66, 246–253 (2017).
Google Scholar
Goldring, M. B. & Marcu, K. B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 11, 224 (2009).
Google Scholar
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J. P. & Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33–42 (2011).
Google Scholar
Sandell, L. J. Etiology of osteoarthritis: genetics and synovial joint development. Nat. Rev. Rheumatol. 8, 77–89 (2012).
Google Scholar
Rim, Y. A., Nam, Y. & Ju, J. H. The role of chondrocyte hypertrophy and senescence in osteoarthritis initiation and progression. Int. J. Mol. Sci. 21, 2358 (2020).
Jeon, O. H. et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23, 775–781 (2017).
Google Scholar
Martin, J. A., Brown, T. D., Heiner, A. D. & Buckwalter, J. A. Chondrocyte senescence, joint loading and osteoarthritis. Clin. Orthop. Relat. Res. S96–S103 (2004).
Price, J. S. et al. The role of chondrocyte senescence in osteoarthritis. Aging cell 1, 57–65 (2002).
Google Scholar
Zhou, H. W., Lou, S. Q. & Zhang, K. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Rheumatology 43, 555–568 (2004).
Google Scholar
Harbo, M. et al. The distribution pattern of critically short telomeres in human osteoarthritic knees. Arthritis Res. Ther. 14, R12 (2012).
Google Scholar
Harbo, M. et al. The relationship between ultra-short telomeres, aging of articular cartilage and the development of human hip osteoarthritis. Mech. Ageing Dev. 134, 367–372 (2013).
Google Scholar
Loeser, R. F. The role of aging in the development of osteoarthritis. Trans. Am. Clin. Climatol. Assoc. 128, 44–54 (2017).
Loeser, R. F., Gandhi, U., Long, D. L., Yin, W. & Chubinskaya, S. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol. 66, 2201–2209 (2014).
Google Scholar
Dai, S. M. et al. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum. 54, 818–831 (2006).
Google Scholar
Yan, H. M. et al. Efficacy of berberine in patients with non-alcoholic fatty liver disease. PLoS ONE 10, e0134172 (2015).
Google Scholar
Hui, W. et al. Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage. Ann. Rheum. Dis. 75, 449–458 (2016).
Google Scholar
Rego-Perez, I., Duran-Sotuela, A., Ramos-Louro, P. & Blanco, F. J. Mitochondrial genetics and epigenetics in osteoarthritis. Front. Genet. 10, 1335 (2019).
Google Scholar
Zheng, L., Zhang, Z., Sheng, P. & Mobasheri, A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res. Rev. 66, 101249 (2021).
Google Scholar
Mobasheri, A. et al. The role of metabolism in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 13, 302–311 (2017).
Google Scholar
Peansukmanee, S. et al. Effects of hypoxia on glucose transport in primary equine chondrocytes in vitro and evidence of reduced GLUT1 gene expression in pathologic cartilage in vivo. J. Orthop. Res. 27, 529–535 (2009).
Google Scholar
Bustamante, M. F. et al. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis. Ann. Rheum. Dis. 77, 1636–1643 (2018).
Google Scholar
Yang, X. et al. Pyruvate kinase M2 modulates the glycolysis of chondrocyte and extracellular matrix in osteoarthritis. DNA Cell Biol. 37, 271–277 (2018).
Google Scholar
Liu-Bryan, R. Inflammation and intracellular metabolism: new targets in OA. Osteoarthr. Cartil. 23, 1835–1842 (2015).
Google Scholar
Terkeltaub, R., Yang, B., Lotz, M. & Liu-Bryan, R. Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1beta and tumor necrosis factor alpha. Arthritis Rheum. 63, 1928–1937 (2011).
Google Scholar
Matsuzaki, T. et al. Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann. Rheum. Dis. 73, 1397–1404 (2014).
Google Scholar
Tsuchida, A. I. et al. Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes. Arthritis Res. Ther. 16, 441 (2014).
Google Scholar
Parfitt, A. M. Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical consequences. Calcif. Tissue Int. 36, S123–S128 (1984).
Google Scholar
Chen, Q. et al. DNA damage drives accelerated bone aging via an NF-kappaB-dependent mechanism. J. Bone Min. Res. 28, 1214–1228 (2013).
Google Scholar
Pignolo, R. J. et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell 7, 23–31 (2008).
Google Scholar
Saeed, H. et al. Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment. J. Bone Min. Res. 26, 1494–1505 (2011).
Google Scholar
Brennan, T. A. et al. Mouse models of telomere dysfunction phenocopy skeletal changes found in human age-related osteoporosis. Dis. Model Mech. 7, 583–592 (2014).
Google Scholar
Saeed, H. et al. Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway. Biogerontology 16, 733–745 (2015).
Google Scholar
Zeng, J., Xiao, Q., Li, X. & Chen, J. Advanced oxidation protein products aggravate agerelated bone loss by increasing sclerostin expression in osteocytes via ROSdependent downregulation of Sirt1. Int. J. Mol. Med. 47, 108 (2021).
Zeng, J. H. et al. Advanced oxidation protein products accelerate bone deterioration in aged rats. Exp. Gerontol. 50, 64–71 (2014).
Google Scholar
Shah, S. et al. P53 regulation of osteoblast differentiation is mediated through specific microRNAs. Biochem. Biophys. Rep. 25, 100920 (2021).
Google Scholar
Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Min. Res. 31, 1920–1929 (2016).
Google Scholar
Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072–1079 (2017).
Google Scholar
Idris, A. I. et al. Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Cell Metab. 10, 139–147 (2009).
Google Scholar
Hu, L. et al. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int. J. Mol. Sci. 19, 360 (2018).
Stenderup, K., Justesen, J., Clausen, C. & Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919–926 (2003).
Google Scholar
Wang, H. et al. Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging. Aging Cell 11, 704–713 (2012).
Google Scholar
Mattiucci, D., Maurizi, G., Leoni, P. & Poloni, A. Aging- and senescence-associated changes of mesenchymal stromal cells in myelodysplastic syndromes. Cell Transpl. 27, 754–764 (2018).
Google Scholar
Guo, Y. et al. Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosis. Redox Biol. 41, 101915 (2021).
Google Scholar
Fathi, E., Charoudeh, H. N., Sanaat, Z. & Farahzadi, R. Telomere shortening as a hallmark of stem cell senescence. Stem Cell Investig. 6, 7 (2019).
Google Scholar
Galderisi, U. et al. In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes. Stem Cells Dev. 18, 1033–1042 (2009).
Google Scholar
Vono, R., Jover Garcia, E., Spinetti, G. & Madeddu, P. Oxidative stress in mesenchymal stem cell senescence: regulation by coding and noncoding RNAs. Antioxid. Redox Signal 29, 864–879 (2018).
Google Scholar
Moerman, E. J., Teng, K., Lipschitz, D. A. & Lecka-Czernik, B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3, 379–389 (2004).
Google Scholar
Christenson, S. A., Smith, B. M., Bafadhel, M. & Putcha, N. Chronic obstructive pulmonary disease. Lancet 399, 2227–2242 (2022).
Google Scholar
Cho, S. J. & Stout-Delgado, H. W. Aging and lung disease. Annu Rev. Physiol. 82, 433–459 (2020).
Google Scholar
Schneider, J. L. et al. The aging lung: physiology, disease, and immunity. Cell 184, 1990–2019 (2021).
Google Scholar
Kurozumi, M., Matsushita, T., Hosokawa, M. & Takeda, T. Age-related changes in lung structure and function in the senescence-accelerated mouse (SAM): SAM-P/1 as a new murine model of senile hyperinflation of lung. Am. J. Respir. Crit. Care Med. 149, 776–782 (1994).
Google Scholar
Ishii, M., Yamaguchi, Y., Yamamoto, H., Hanaoka, Y. & Ouchi, Y. Airspace enlargement with airway cell apoptosis in klotho mice: a model of aging lung. J. Gerontol. A Biol. Sci. Med. Sci. 63, 1289–1298 (2008).
Google Scholar
Proenca de Oliveira-Maul, J. et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest 143, 1091–1097 (2013).
Google Scholar
Tsuji, T., Aoshiba, K. & Nagai, A. Alveolar cell senescence in patients with pulmonary emphysema. Am. J. Respir. Crit. Care Med. 174, 886–893 (2006).
Google Scholar
Martinez de Toda, I., Mate, I., Vida, C., Cruces, J. & De la Fuente, M. Immune function parameters as markers of biological age and predictors of longevity. Aging 8, 3110–3119 (2016).
Google Scholar
Kuwano, K. et al. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Respir. Investig. 54, 397–406 (2016).
Google Scholar
Bodas, M., Patel, N., Silverberg, D., Walworth, K. & Vij, N. Master autophagy regulator transcription factor EB eegulates cigarette smoke-induced autophagy impairment and chronic obstructive pulmonary disease-emphysema pathogenesis. Antioxid. Redox Signal. 27, 150–167 (2017).
Google Scholar
Yamada, Y. et al. Decreased proteasomal function accelerates cigarette smoke-induced pulmonary emphysema in mice. Lab Invest. 95, 625–634 (2015).
Google Scholar
Barnes, P. J., Baker, J. & Donnelly, L. E. Autophagy in asthma and chronic obstructive pulmonary disease. Clin. Sci. 136, 733–746 (2022).
Google Scholar
Mumby, S. & Adcock, I. M. Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD. J. Inflamm. 19, 10 (2022).
Google Scholar
Wiegman, C. H. et al. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 136, 769–780 (2015).
Google Scholar
Araya, J. et al. PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. Autophagy 15, 510–526 (2019).
Google Scholar
Tsubouchi, K., Araya, J. & Kuwano, K. PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses. Inflamm. Regen. 38, 18 (2018).
Google Scholar
Vucic, E. A. et al. DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am. J. Respir. Cell Mol. Biol. 50, 912–922 (2014).
Google Scholar
Qiu, W. et al. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am. J. Respir. Crit. Care Med. 185, 373–381 (2012).
Google Scholar
Rajendrasozhan, S., Yang, S. R., Kinnula, V. L. & Rahman, I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177, 861–870 (2008).
Google Scholar
Hodge, G. et al. Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes. Respir. Res. 16, 130 (2015).
Google Scholar
Mercado, N. et al. Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem. Biophys. Res. Commun. 406, 292–298 (2011).
Google Scholar
Yao, H. et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J. Clin. Invest. 122, 2032–2045 (2012).
Google Scholar
Baker, J. R. et al. MicroRNA-570 is a novel regulator of cellular senescence and inflammaging. FASEB J. 33, 1605–1616 (2019).
Google Scholar
Gu, C. et al. LncRNAmediated SIRT1/FoxO3a and SIRT1/p53 signaling pathways regulate type II alveolar epithelial cell senescence in patients with chronic obstructive pulmonary disease. Mol. Med. Rep. 15, 3129–3134 (2017).
Google Scholar
Ganesan, S. et al. Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A. Thorax 68, 131–141 (2013).
Google Scholar
Hwang, J. W. et al. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. J. Immunol. 187, 987–998 (2011).
Google Scholar
Cheng, X. Y., Li, Y. Y., Huang, C., Li, J. & Yao, H. W. AMP-activated protein kinase reduces inflammatory responses and cellular senescence in pulmonary emphysema. Oncotarget 8, 22513–22523 (2017).
Google Scholar
Caramori, G. et al. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax 66, 521–527 (2011).
Google Scholar
Ceylan, E., Kocyigit, A., Gencer, M., Aksoy, N. & Selek, S. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir. Med. 100, 1270–1276 (2006).
Google Scholar
Albrecht, E. et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur. Respir. J. 43, 983–992 (2014).
Google Scholar
Nyunoya, T. et al. Cigarette smoke induces cellular senescence via Werner’s syndrome protein down-regulation. Am. J. Respir. Crit. Care Med. 179, 279–287 (2009).
Google Scholar
Rossiello, F., Jurk, D., Passos, J. F. & d’Adda di Fagagna, F. Telomere dysfunction in ageing and age-related diseases. Nat. Cell Biol. 24, 135–147 (2022).
Google Scholar
Ahmad, T. et al. Shelterin telomere protection protein 1 reduction causes telomere attrition and cellular senescence via sirtuin 1 deacetylase in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 56, 38–49 (2017).
Google Scholar
Chen, R. et al. Telomerase deficiency causes alveolar stem cell senescence-associated low-grade inflammation in lungs. J. Biol. Chem. 290, 30813–30829 (2015).
Google Scholar
Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463–2479 (2010).
Welén, K. & Damber, J. E. Androgens, aging, and prostate health. Rev. Endocr. Metab. Disord. 6, 62–77 (2022).
Shukla, G. C., Plaga, A. R., Shankar, E. & Gupta, S. Androgen receptor-related diseases: what do we know? Andrology 4, 366–381 (2016).
Google Scholar
Jin, R. et al. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients. Prostate 82, 1378–1388 (2022).
Google Scholar
Tsunemori, H. & Sugimoto, M. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: a literature review. Int. J. Urol. 28, 1086–1092 (2021).
Google Scholar
Kramer, G., Mitteregger, D. & Marberger, M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 51, 1202–1216 (2007).
Google Scholar
Penna, G. et al. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation. J. Immunol. 182, 4056–4064 (2009).
Google Scholar
Xiong, Y., Zhang, Y., Tan, J., Qin, F. & Yuan, J. The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching. Transl. Androl. Urol. 10, 384–396 (2021).
Google Scholar
Xia, B. W. et al. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume. Prostate 80, 481–490 (2020).
Google Scholar
Garcia-Garcia, J. et al. Pathophysiology of age-related macular degeneration. Implications for treatment. Ophthalmic Res. (2022).
Deng, Y. et al. Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 9, 62–79 (2022).
Google Scholar
Chaum, E., Winborn, C. S. & Bhattacharya, S. Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium. Mamm. Genome 26, 210–221 (2015).
Google Scholar
Lopez-Luppo, M. et al. Cellular senescence is associated with human retinal microaneurysm formation during aging. Invest. Ophthalmol. Vis. Sci. 58, 2832–2842 (2017).
Google Scholar
Cabrera, A. P. et al. Senescence increases choroidal endothelial stiffness and susceptibility to complement injury: implications for choriocapillaris loss in AMD. Invest. Ophthalmol. Vis. Sci. 57, 5910–5918 (2016).
Google Scholar
Damani, M. R. et al. Age-related alterations in the dynamic behavior of microglia. Aging cell 10, 263–276 (2011).
Google Scholar
Lee, K. S., Lin, S., Copland, D. A., Dick, A. D. & Liu, J. Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration. J. Neuroinflammation 18, 32 (2021).
Google Scholar
Copland, D. A., Theodoropoulou, S., Liu, J. & Dick, A. D. A perspective of AMD through the eyes of immunology. Invest. Ophthalmol. Vis. Sci. 59, AMD83–AMD92 (2018).
Google Scholar
Cao, L. et al. Abeta-induced senescent retinal pigment epithelial cells create a proinflammatory microenvironment in AMD. Invest. Ophthalmol. Vis. Sci. 54, 3738–3750 (2013).
Google Scholar
Blasiak, J. Senescence in the pathogenesis of age-related macular degeneration. Cell Mol. Life Sci. 77, 789–805 (2020).
Google Scholar
Lin, J. B. et al. Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration. JCI insight 3, e120157 (2018).
Sene, A. et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 17, 549–561 (2013).
Google Scholar
Zhao, C. et al. mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J. Clin. Invest. 121, 369–383 (2011).
Google Scholar
Jadeja, R. N. et al. Loss of NAMPT in aging retinal pigment epithelium reduces NAD(+) availability and promotes cellular senescence. Aging 10, 1306–1323 (2018).
Google Scholar
Zhang, M. et al. Dysregulated metabolic pathways in age-related macular degeneration. Sci. Rep. 10, 2464 (2020).
Google Scholar
Chen, Y., Wang, J., Cai, J. & Sternberg, P. Altered mTOR signaling in senescent retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 51, 5314–5319 (2010).
Google Scholar
Kozhevnikova, O. S., Telegina, D. V., Devyatkin, V. A. & Kolosova, N. G. Involvement of the autophagic pathway in the progression of AMD-like retinopathy in senescence-accelerated OXYS rats. Biogerontology 19, 223–235 (2018).
Google Scholar
Golestaneh, N., Chu, Y., Xiao, Y. Y., Stoleru, G. L. & Theos, A. C. Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis. 8, e2537 (2017).
Google Scholar
Ferrington, D. A., Sinha, D. & Kaarniranta, K. Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. Prog. Retin. Eye Res. 51, 69–89 (2016).
Google Scholar
Plotegher, N. & Duchen, M. R. Crosstalk between lysosomes and mitochondria in Parkinson’s disease. Front. Cell Dev. Biol. 5, 110 (2017).
Google Scholar
Konig, J. et al. Mitochondrial contribution to lipofuscin formation. Redox Biol. 11, 673–681 (2017).
Google Scholar
Hohn, A., Jung, T., Grimm, S. & Grune, T. Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. Free Radic. Biol. Med. 48, 1100–1108 (2010).
Google Scholar
McLaughlin, T. et al. Loss of XBP1 accelerates age-related decline in retinal function and neurodegeneration. Mol. Neurodegener. 13, 16 (2018).
Google Scholar
Sun, Q. et al. Inhibition of sumoylation alleviates oxidative stress-induced retinal pigment epithelial cell senescence and represses proinflammatory gene expression. Curr. Mol. Med. 18, 575–583 (2018).
Google Scholar
Campello, L., Esteve-Rudd, J., Cuenca, N. & Martin-Nieto, J. The ubiquitin-proteasome system in retinal health and disease. Mol. Neurobiol. 47, 790–810 (2013).
Google Scholar
Rohrer, B., Bandyopadhyay, M. & Beeson, C. Reduced metabolic capacity in aged primary retinal pigment epithelium (RPE) is correlated with increased susceptibility to oxidative stress. Adv. Exp. Med. Biol. 854, 793–798 (2016).
Google Scholar
Minasyan, L., Sreekumar, P. G., Hinton, D. R. & Kannan, R. Protective mechanisms of the mitochondrial-derived peptide humanin in oxidative and endoplasmic reticulum stress in RPE cells. Oxid. Med. Cell Longev. 2017, 1675230 (2017).
Google Scholar
Chae, S. Y., Park, S. Y. & Park, G. Lutein protects human retinal pigment epithelial cells from oxidative stressinduced cellular senescence. Mol. Med. Rep. 18, 5182–5190 (2018).
Google Scholar
Alhasani, R. H. et al. Tauroursodeoxycholic acid protects retinal pigment epithelial cells from oxidative injury and endoplasmic reticulum stress in vitro. Biomedicines 8, 367 (2020).
Jun, B. et al. Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity. Sci. Rep. 7, 5279 (2017).
Google Scholar
Kaarniranta, K., Pawlowska, E., Szczepanska, J., Jablkowska, A. & Blasiak, J. Role of mitochondrial DNA damage in ROS-mediated pathogenesis of age-related macular degeneration (AMD). Int. J. Mol. Sci. 20, 2374 (2019).
Ferrington, D. A. et al. Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration. Exp. Eye Res. 145, 269–277 (2016).
Google Scholar
Salero, E. et al. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 10, 88–95 (2012).
Google Scholar
Wang, J. & Puel, J. L. Presbycusis: an update on cochlear mechanisms and therapies. J. Clin. Med. 9, 218 (2020).
Miwa, T., Wei, F. Y. & Tomizawa, K. Cdk5 regulatory subunit-associated protein 1 knockout mice show hearing loss phenotypically similar to age-related hearing loss. Mol. Brain 14, 82 (2021).
Google Scholar
Markaryan, A., Nelson, E. G. & Hinojosa, R. Major arc mitochondrial DNA deletions in cytochrome c oxidase-deficient human cochlear spiral ganglion cells. Acta Otolaryngol. 130, 780–787 (2010).
Google Scholar
Menardo, J. et al. Oxidative stress, inflammation, and autophagic stress as the key mechanisms of premature age-related hearing loss in SAMP8 mouse Cochlea. Antioxid. Redox Signal 16, 263–274 (2012).
Google Scholar
Tian, C. et al. Suppressed expression of LDHB promotes age-related hearing loss via aerobic glycolysis. Cell Death Dis. 11, 375 (2020).
Google Scholar
Someya, S. et al. Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proc. Natl Acad. Sci. USA 106, 19432–19437 (2009).
Google Scholar
Prasad, K. N. & Bondy, S. C. Increased oxidative stress, inflammation, and glutamate: potential preventive and therapeutic targets for hearing disorders. Mech. Ageing Dev. 185, 111191 (2020).
Google Scholar
Kwon, T. J. et al. Methionine sulfoxide reductase A, B1 and B2 are likely to be involved in the protection against oxidative stress in the inner ear. Cells Tissues Organs 199, 294–300 (2014).
Google Scholar
Keithley, E. M. et al. Cu/Zn superoxide dismutase and age-related hearing loss. Hear. Res. 209, 76–85 (2005).
Google Scholar
Peixoto Pinheiro, B. et al. Age-related hearing loss pertaining to potassium ion channels in the cochlea and auditory pathway. Pflug. Arch. 473, 823–840 (2021).
Google Scholar
Kim, Y. J. et al. BCL2 interacting protein 3-like/NIX-mediated mitophagy plays an important role in the process of age-related hearing loss. Neuroscience 455, 39–51 (2021).
Google Scholar
Xiong, H. et al. Modulation of miR-34a/SIRT1 signaling protects cochlear hair cells against oxidative stress and delays age-related hearing loss through coordinated regulation of mitophagy and mitochondrial biogenesis. Neurobiol. Aging 79, 30–42 (2019).
Google Scholar
Kociszewska, D. & Vlajkovic, S. Age-related hearing loss: the link between inflammaging, immunosenescence, and gut dysbiosis. Int. J. Mol. Sci. 23, 7348 (2022).
Watson, N., Ding, B., Zhu, X. & Frisina, R. D. Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapy. Ageing Res. Rev. 40, 142–148 (2017).
Google Scholar
Verschuur, C., Agyemang-Prempeh, A. & Newman, T. A. Inflammation is associated with a worsening of presbycusis: evidence from the MRC national study of hearing. Int. J. Audio. 53, 469–475 (2014).
Google Scholar
Lasisi, A. O. & Fehintola, F. A. Correlation between plasma levels of radical scavengers and hearing threshold among elderly subjects with age-related hearing loss. Acta Otolaryngol. 131, 1160–1164 (2011).
Google Scholar
Nash, S. D. et al. Long-term assessment of systemic inflammation and the cumulative incidence of age-related hearing impairment in the epidemiology of hearing loss study. Gerontol. A Biol. Sci. Med. Sci. 69, 207–214 (2014).
Google Scholar
Noble, K. V., Liu, T., Matthews, L. J., Schulte, B. A. & Lang, H. Age-related changes in immune cells of the human cochlea. Front. Neurol. 10, 895 (2019).
Google Scholar
Su, Z. et al. Transcriptomic analysis highlights cochlear inflammation associated with age-related hearing loss in C57BL/6 mice using next generation sequencing. PeerJ 8, e9737 (2020).
Google Scholar
Trifunovic, A. et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl Acad. Sci. USA 102, 17993–17998 (2005).
Google Scholar
Valavanidis, A., Vlachogianni, T. & Fiotakis, C. 8-hydroxy-2’ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 27, 120–139 (2009).
Google Scholar
Benkafadar, N. et al. ROS-induced activation of DNA damage responses drives senescence-like state in postmitotic cochlear cells: implication for hearing preservation. Mol. Neurobiol. 56, 5950–5969 (2019).
Google Scholar
Falah, M. et al. The potential role for use of mitochondrial DNA copy number as predictive biomarker in presbycusis. Ther. Clin. Risk Manag. 12, 1573–1578 (2016).
Google Scholar
Bai, U., Seidman, M. D., Hinojosa, R. & Quirk, W. S. Mitochondrial DNA deletions associated with aging and possibly presbycusis: a human archival temporal bone study. Am. J. Otol. 18, 449–453 (1997).
Google Scholar
Markaryan, A., Nelson, E. G. & Hinojosa, R. Quantification of the mitochondrial DNA common deletion in presbycusis. Laryngoscope 119, 1184–1189 (2009).
Google Scholar
Wu, X. et al. Reduced expression of Connexin26 and its DNA promoter hypermethylation in the inner ear of mimetic aging rats induced by d-galactose. Biochem. Biophys. Res. Commun. 452, 340–346 (2014).
Google Scholar
Xu, J. et al. Elevated SLC26A4 gene promoter methylation is associated with the risk of presbycusis in men. Mol. Med. Rep. 16, 347–352 (2017).
Google Scholar
Bouzid, A. et al. Down-expression of P2RX2, KCNQ5, ERBB3 and SOCS3 through DNA hypermethylation in elderly women with presbycusis. Biomarkers 23, 347–356 (2018).
Google Scholar
Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer – role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619–636 (2022).
Google Scholar
Wang, L., Lankhorst, L. & Bernards, R. Exploiting senescence for the treatment of cancer. Nat. Rev. Cancer 22, 340–355 (2022).
Google Scholar
Tasdemir, N. et al. BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Disco. 6, 612–629 (2016).
Google Scholar
Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660 (2007).
Google Scholar
Ortiz-Montero, P., Londono-Vallejo, A. & Vernot, J. P. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun. Signal 15, 17 (2017).
Google Scholar
Coppe, J. P., Kauser, K., Campisi, J. & Beausejour, C. M. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281, 29568–29574 (2006).
Google Scholar
Chen, C. et al. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-kappaB pathway in colorectal cancer. Cell Death Dis. 10, 178 (2019).
Google Scholar
Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52–67 (2010).
Google Scholar
Guccini, I. et al. Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis. Cancer Cell 39, 68–82.e69 (2021).
Google Scholar
Ruhland, M. K. et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat. Commun. 7, 11762 (2016).
Google Scholar
Di Mitri, D. et al. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature 515, 134–137 (2014).
Google Scholar
Eggert, T. et al. Distinct functions of senescence-associated immune responses in liver tumor Surveillance and tumor progression. Cancer Cell 30, 533–547 (2016).
Google Scholar
Kivipelto, M. et al. The Finnish Geriatric Intervention Study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimers Dement. 9, 657–665 (2013).
Google Scholar
Lehtisalo, J. et al. Dietary changes and cognition over 2 years within a multidomain intervention trial-The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER). Alzheimers Dement. 15, 410–417 (2019).
Google Scholar
Kivipelto, M., Mangialasche, F. & Ngandu, T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat. Rev. Neurol. 14, 653–666 (2018).
Google Scholar
Vinciguerra, F. & Graziano, M. Influence of the Mediterranean and Ketogenic diets on cognitive status and decline: a narrative review. Nutrients 12, 1019 (2020).
Google Scholar
De la Rosa, A. et al. Physical exercise in the prevention and treatment of Alzheimer’s disease. J. Sport Health Sci. 9, 394–404 (2020).
Google Scholar
Hardy, J. A. & Higgins, G. A. Alzheimer’s disease: the amyloid cascade hypothesis. Science 256, 184–185 (1992).
Google Scholar
Sevigny, J. et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537, 50–56 (2016).
Google Scholar
Miziak, B., Błaszczyk, B. & Czuczwar, S. J. Some candidate drugs for pharmacotherapy of Alzheimer’s disease. Pharmaceuticals 14, 458 (2021).
Luchsinger, J. A. et al. Metformin, lifestyle intervention, and cognition in the diabetes prevention program outcomes study. Diabetes Care 40, 958–965 (2017).
Google Scholar
Koenig, A. M. et al. Effects of the insulin sensitizer metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis. Assoc. Disord. 31, 107–113 (2017).
Google Scholar
Mitchell, E. S., Conus, N. & Kaput, J. B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci. Biobehav. Rev. 47, 307–320 (2014).
Google Scholar
Román, G. C. & Mancera-Páez, O. Epigenetic factors in late-onset Alzheimer’s disease: MTHFR and CTH gene polymorphisms, metabolic transsulfuration and methylation pathways, and B vitamins. Int. J. Mol. Sci. 20, 319 (2019).
Google Scholar
Yuksel, J. M., Noviasky, J. & Britton, S. Aducanumab for Alzheimer’s disease: summarized data from EMERGE, ENGAGE, and PRIME studies. Sr. Care Pharm. 37, 329–334 (2022).
Google Scholar
Knopman, D. S., Jones, D. T. & Greicius, M. D. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement. 17, 696–701 (2021).
Google Scholar
Kuller, L. H. & Lopez, O. L. ENGAGE and EMERGE: truth and consequences? Alzheimers Dement. 17, 692–695 (2021).
Google Scholar
Remya, C. et al. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation. Comput. Struct. Biotechnol. J. 19, 4517–4537 (2021).
Google Scholar
Korabecny, J. et al. A systematic review on donepezil-based derivatives as potential cholinesterase inhibitors for Alzheimer’s disease. Curr. Med. Chem. 26, 5625–5648 (2019).
Google Scholar
Uddin, M. S. et al. Multi-target drug candidates for multifactorial Alzheimer’s disease: AChE and NMDAR as molecular targets. Mol. Neurobiol. 58, 281–303 (2021).
Google Scholar
Davies, P. & Maloney, A. J. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2, 1403 (1976).
Google Scholar
Bortolami, M. et al. Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016-present). Expert Opin. Ther. Pat. 31, 399–420 (2021).
Google Scholar
Saeedi, M. & Mehranfar, F. Challenges and approaches of drugs such as memantine, donepezil, rivastigmine, and aducanumab in the treatment, control and management of Alzheimer’s disease. Recent Pat. Biotechnol. 16, 102–121 (2022).
Google Scholar
Román, G. C., Jackson, R. E., Gadhia, R., Román, A. N. & Reis, J. Mediterranean diet: the role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease. Rev. Neurol. 175, 724–741 (2019).
Google Scholar
Howes, M. R., Fang, R. & Houghton, P. J. Effect of Chinese herbal medicine on Alzheimer’s disease. Int. Rev. Neurobiol. 135, 29–56 (2017).
Google Scholar
Li, Q. et al. Current progress on neuroprotection induced by Artemisia, Ginseng, Astragalus, and Ginkgo traditional Chinese medicines for the therapy of Alzheimer’s disease. Oxid. Med. Cell Longev. 2022, 1–21 (2022).
Kerr, J. S. et al. Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci. 40, 151–166 (2017).
Google Scholar
Sun, N., Youle, R. J. & Finkel, T. The mitochondrial basis of aging. Mol. Cell 61, 654–666 (2016).
Google Scholar
Xie, C. et al. Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat. Biomed. Eng. 6, 76–93 (2022).
Google Scholar
de Carvalho, T. S. Calorie restriction or dietary restriction: how far they can protect the brain against neurodegenerative diseases? Neural Regen. Res. 17, 1640–1644 (2022).
Google Scholar
Ciulla, M., Marinelli, L. & Cacciatore, I. Role of dietary supplements in the management of Parkinson’s disease. Biomolecules 9, 271 (2019).
Google Scholar
Abdul-Latif, R., Stupans, I., Allahham, A., Adhikari, B. & Thrimawithana, T. Natural antioxidants in the management of Parkinson’s disease: review of evidence from cell line and animal models. J. Integr. Med. 19, 300–310 (2021).
Google Scholar
Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD(+) in brain aging and neurodegenerative disorders. Cell Metab. 30, 630–655 (2019).
Google Scholar
Zeng, B. Y. Effect and mechanism of Chinese herbal medicine on Parkinson’s disease. Int. Rev. Neurobiol. 135, 57–76 (2017).
Google Scholar
Baker, D. J. & Petersen, R. C. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J. Clin. Invest. 128, 1208–1216 (2018).
Google Scholar
Hou, Y., Dan, X., Babbar, M., Wei, Y. & Hasselbalch, S. G. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565–581 (2019).
Google Scholar
Wamelen, D. J. V., Rukavina, K., Podlewska, A. M. & Chaudhuri, K. R. Advances in the pharmacological and non-pharmacological management of non-motor symptoms in Parkinson’s disease: an update since 2017. Curr. Neuropharmacol. (2022).
Hvingelby, V. S. et al. Interventions to improve gait in Parkinson’s disease: a systematic review of randomized controlled trials and network meta-analysis. J. Neurol. 269, 4068–4079 (2022).
Google Scholar
Paz, R. M. & Murer, M. G. Mechanisms of antiparkinsonian anticholinergic therapy revisited. Neuroscience 467, 201–217 (2021).
Google Scholar
Vaikath, N. N. et al. Antibodies against alpha-synuclein: tools and therapies. J. Neurochem. 150, 612–625 (2019).
Google Scholar
Vermersch, P. et al. Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial. Neurol. Neuroimmunol. Neuroinflamm. 9, e1148 (2022).
Google Scholar
Vermersch, P., Brieva-Ruiz, L. & Fox, R. J. Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial. Neurol. Neuroimmunol. Neuroinflamm. 9, e114 (2022).
Google Scholar
Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell 167, 1469–1480.e1412 (2016).
Google Scholar
Palmer, K., Bowles, K. A., Paton, M., Jepson, M. & Lane, R. Chronic heart failure and exercise rehabilitation: a systematic review and meta-analysis. Arch. Phys. Med. Rehabil. 99, 2570–2582 (2018).
Google Scholar
Tsao, C. W. et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 145, e153–e639 (2022).
Google Scholar
Casaletto, K. B. et al. Microglial correlates of late life physical activity: relationship with synaptic and cognitive aging in older adults. J. Neurosci. 42, 288–298 (2022).
Google Scholar
Nassif, M. E. et al. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat. Med. 27, 1954–1960 (2021).
Google Scholar
Jia, K. et al. Senolytic agent navitoclax inhibits angiotensin II-induced heart failure in mice. J. Cardiovasc. Pharm. 76, 452–460 (2020).
Google Scholar
Bernardes de Jesus, B. et al. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 10, 604–621 (2011).
Google Scholar
Wang, J. et al. Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling. Biomed. Pharmacother. 107, 1074–1081 (2018).
Google Scholar
Szabo, N. J. Dietary safety of cycloastragenol from Astragalus spp.: subchronic toxicity and genotoxicity studies. Food Chem. Toxicol. 64, 322–334 (2014).
Google Scholar
Chiang, J. T. et al. Anti-apoptosis and anti-fibrosis effects of Eriobotrya japonica in spontaneously hypertensive rat hearts. Int. J. Mol. Sci. 19, 1638 (2018).
Chang, Y. M. et al. Anti-apoptotic and pro-survival effect of alpinate oxyphyllae fructus (AOF) in a d-galactose-induced aging heart. Int. J. Mol. Sci. 17, 466 (2016).
Google Scholar
Zhou, G. et al. A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii Debeaux. J. Ethnopharmacol. 160, 173–193 (2015).
Google Scholar
Li, J. et al. Long-term repopulation of aged bone marrow stem cells using young Sca-1 cells promotes aged heart rejuvenation. Aging Cell 18, e13026 (2019).
Google Scholar
Lv, S., Wang, Y., Zhang, W. & Shang, H. Trimethylamine oxide: a potential target for heart failure therapy. Heart 108, 917–922 (2022).
Google Scholar
Lin, H. et al. Yellow wine polyphenolic compound protects against doxorubicin-induced cardiotoxicity by modulating the composition and metabolic function of the gut microbiota. Circ. Heart Fail. 14, e008220 (2021).
Google Scholar
Han, Z. L. et al. Potassium alginate oligosaccharides alter gut microbiota, and have potential to prevent the development of hypertension and heart failure in spontaneously hypertensive rats. Int. J. Mol.Sci. 22, 9823 (2021).
Visseren, F. L. J. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. J. Prev. Cardiol. 29, 5–115 (2022).
Google Scholar
Torres, N., Guevara-Cruz, M., Velazquez-Villegas, L. A. & Tovar, A. R. Nutrition and atherosclerosis. Arch. Med. Res. 46, 408–426 (2015).
Google Scholar
Ros, E. et al. Mediterranean diet and cardiovascular health: teachings of the PREDIMED study. Adv. Nutr. 5, 330S–336S (2014).
Google Scholar
Perez-Lopez, F. R., Chedraui, P., Haya, J. & Cuadros, J. L. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 64, 67–79 (2009).
Google Scholar
Marin, C., Yubero-Serrano, E. M., Lopez-Miranda, J. & Perez-Jimenez, F. Endothelial aging associated with oxidative stress can be modulated by a healthy mediterranean diet. Int. J. Mol. Sci. 14, 8869–8889 (2013).
Google Scholar
Jiang, Y. H., Jiang, L. Y., Wang, Y. C., Ma, D. F. & Li, X. Quercetin attenuates atherosclerosis via modulating oxidized LDL-induced endothelial cellular senescence. Front. Pharm. 11, 512 (2020).
Google Scholar
Roos, C. M. et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell 15, 973–977 (2016).
Google Scholar
Karnewar, S. et al. Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: relevance in age-associated vascular dysfunction. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 1115–1128 (2018).
Google Scholar
Martin-Montalvo, A. et al. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4, 2192 (2013).
Google Scholar
Huang, D. et al. Bazi Bushen capsule alleviates post-menopausal atherosclerosis via GPER1-dependent anti-inflammatory and anti-apoptotic effects. Front. Pharm. 12, 658998 (2021).
Google Scholar
Zimetti, F. et al. The natural compound berberine positively affects macrophage functions involved in atherogenesis. Nutr. Metab. Cardiovasc Dis. 25, 195–201 (2015).
Google Scholar
Zheng, Y. et al. Berberine-induced TFEB deacetylation by SIRT1 promotes autophagy in peritoneal macrophages. Aging 13, 7096–7119 (2021).
Google Scholar
Ma, S. R. et al. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota. Signal Transduct. Target Ther. 7, 207 (2022).
Google Scholar
Weber, M. B., Gujral, U. P., Jagannathan, R. & Shah, M. Lifestyle interventions for diabetes prevention in South Asians: current evidence and opportunities. Curr. Diab. Rep. 21, 23 (2021).
Google Scholar
Ho, M. et al. Effects of dietary and physical activity interventions on generic and cancer-specific health-related quality of life, anxiety, and depression in colorectal cancer survivors: a randomized controlled trial. J. Cancer Surviv. 14, 424–433 (2020).
Google Scholar
Murakami, T., Inagaki, N. & Kondoh, H. Cellular senescence in diabetes mellitus: distinct senotherapeutic strategies for adipose tissue and pancreatic beta cells. Front. Endocrinol. 13, 869414 (2022).
Google Scholar
Schoenwaelder, S. M. et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 118, 1663–1674 (2011).
Google Scholar
Thompson, P. J. et al. Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell Metab. 29, 1045–1060.e1010 (2019).
Google Scholar
Novais, E. J. et al. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun. 12, 5213 (2021).
Google Scholar
Zoico, E. et al. Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence. Sci. Rep. 11, 23237 (2021).
Google Scholar
Raffaele, M. et al. Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin. Cell Commun. Signal 19, 44 (2021).
Google Scholar
Luo, G. et al. Resveratrol attenuates excessive ethanol exposure-induced beta-cell senescence in rats: a critical role for the NAD(+)/SIRT1-p38MAPK/p16 pathway. J. Nutr. Biochem. 89, 108568 (2021).
Google Scholar
Kulkarni, A. S., Gubbi, S. & Barzilai, N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 32, 15–30 (2020).
Google Scholar
Liu, J. et al. Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes. Aging 11, 741–755 (2019).
Google Scholar
Saisho, Y. Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr. Metab. Immune Disord. Drug Targets 15, 196–205 (2015).
Google Scholar
Dogan Turacli, I. et al. Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes. Biochimie 154, 62–68 (2018).
Google Scholar
de la Cuesta-Zuluaga, J. et al. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40, 54–62 (2017).
Google Scholar
Smith, A. D. et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 5, e12244 (2010).
Google Scholar
Tang, C. et al. Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. Diabetologia 55, 1366–1379 (2012).
Google Scholar
Kim, M. J. et al. Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes. Metabolism 97, 87–91 (2019).
Google Scholar
Zhang, Y. et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat. Commun. 11, 5015 (2020).
Google Scholar
Gepner, Y. et al. Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial. Circulation 137, 1143–1157 (2018).
Google Scholar
Abenavoli, L. et al. Dietary polyphenols and non-alcoholic fatty liver disease. Nutrients 13, 494 (2021).
Google Scholar
An, H. S. et al. Caloric restriction reverses left ventricular hypertrophy through the regulation of cardiac iron homeostasis in impaired leptin signaling mice. Sci. Rep. 10, 7176 (2020).
Google Scholar
Branković, M. et al. Lipotoxicity as the leading cause of non-alcoholic steatohepatitis. Int. J. Mol. Sci. 23, 5146 (2022).
Google Scholar
Craven, L. et al. Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial. Am. J. Gastroenterol. 115, 1055–1065 (2020).
Google Scholar
Armstrong, M. J. et al. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 387, 679–690 (2016).
Google Scholar
Gawrieh, S. et al. Saroglitazar, a PPAR-alpha/gamma agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial. Hepatology 74, 1809–1824 (2021).
Google Scholar
Ratziu, V. et al. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology 150, 1147–1159.e1145 (2016).
Google Scholar
Lan, T. et al. Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway. Hepatology 74, 686–703 (2021).
Google Scholar
Lan, T. et al. Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling. Hepatology 76, 155–171 (2022).
Google Scholar
Hickson, L. J. et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446–456 (2019).
Google Scholar
Nogueira-Recalde, U. et al. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine 45, 588–605 (2019).
Google Scholar
Yousefzadeh, M. J. et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36, 18–28 (2018).
Google Scholar
Zheng, W. et al. Fisetin inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice. Int. Immunopharmacol. 45, 135–147 (2017).
Google Scholar
Chang, J. et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22, 78–83 (2016).
Google Scholar
Fleischmann, R. M. et al. A phase II trial of lutikizumab, an anti-interleukin-1alpha/beta dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis. Arthritis Rheumatol. 71, 1056–1069 (2019).
Google Scholar
Kloppenburg, M. et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis. 77, 1757–1764 (2018).
Google Scholar
Schieker, M. et al. Effects of interleukin-1beta inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 173, 509–515 (2020).
Google Scholar
Wang, M. et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res. Ther. 15, R5 (2013).
Google Scholar
Feng, K., Chen, Z., Pengcheng, L., Zhang, S. & Wang, X. Quercetin attenuates oxidative stress-induced apoptosis via SIRT1/AMPK-mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model. J. Cell Physiol. 234, 18192–18205 (2019).
Google Scholar
Piao, S. et al. Protectin DX attenuates IL-1beta-induced inflammation via the AMPK/NF-kappaB pathway in chondrocytes and ameliorates osteoarthritis progression in a rat model. Int. Immunopharmacol. 78, 106043 (2020).
Google Scholar
Ye, J. et al. Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice. Aging 12, 193–203 (2020).
Google Scholar
Arriola Apelo, S. I. & Lamming, D. W. Rapamycin: an InhibiTOR of Aging Emerges From the Soil of Easter Island. J. Gerontol. A Biol. Sci. Med. Sci. 71, 841–849 (2016).
Google Scholar
Wang, B., Sun, W., Bi, K., Li, Y. & Li, F. Apremilast prevents IL17induced cellular senescence in ATDC5 chondrocytes mediated by SIRT1. Int. J. Mol. Med. 47, 12 (2021).
Khan, N. M. et al. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes. Free Radic. Biol. Med. 106, 288–301 (2017).
Google Scholar
Liu, F. C. et al. Chondroprotective effects of genistein against osteoarthritis induced joint inflammation. Nutrients 11, 1180 (2019).
Park, C. et al. Sargassum serratifolium extract attenuates interleukin-1beta-induced oxidative stress and inflammatory response in chondrocytes by suppressing the activation of NF-kappaB, p38 MAPK, and PI3K/Akt. Int. J. Mol. Sci. 19, 2308 (2018).
Wu, Y. et al. Sinomenine contributes to the inhibition of the inflammatory response and the improvement of osteoarthritis in mouse-cartilage cells by acting on the Nrf2/HO-1 and NF-kappaB signaling pathways. Int. Immunopharmacol. 75, 105715 (2019).
Google Scholar
Xu, M. et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age. Elife 4, e12997 (2015).
Google Scholar
Zhu, Y. et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14, 644–658 (2015).
Google Scholar
Wong, S. K., Chin, K. Y. & Ima-Nirwana, S. Quercetin as an agent for protecting the bone: a review of the current evidence. Int. J. Mol. Sci. 21, 6448 (2020).
Xu, M. et al. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl Acad. Sci. USA 112, E6301–E6310 (2015).
Google Scholar
Lv, Y. J. et al. Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice. Theranostics 8, 2387–2406 (2018).
Google Scholar
Chen, X. et al. Nrf2 epigenetic derepression induced by running exercise protects against osteoporosis. Bone Res. 9, 15 (2021).
Google Scholar
Jiang, Y., Zhang, P., Zhang, X., Lv, L. & Zhou, Y. Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Prolif. 54, e12956 (2021).
Google Scholar
Qi, X. et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int. J. Biol. Sci. 12, 836–849 (2016).
Google Scholar
Zuo, R. et al. BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt/beta-catenin signaling. Stem Cell Res. Ther. 10, 30 (2019).
Google Scholar
Li, L. et al. Exosomal miR-186 derived from BMSCs promote osteogenesis through hippo signaling pathway in postmenopausal osteoporosis. J. Orthop. Surg. Res. 16, 23 (2021).
Google Scholar
Zhang, Y. et al. microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats. Life Sci. 272, 119204 (2021).
Google Scholar
Xun, J. et al. Serum exosomes from young rats improve the reduced osteogenic differentiation of BMSCs in aged rats with osteoporosis after fatigue loading in vivo. Stem Cell Res. Ther. 12, 424 (2021).
Google Scholar
Wang, Y. et al. Bone-targeted extracellular vesicles from mesenchymal stem cells for osteoporosis therapy. Int. J. Nanomed. 15, 7967–7977 (2020).
Google Scholar
Justice, J. N. et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine 40, 554–563 (2019).
Google Scholar
Baker, J. R., Donnelly, L. E. & Barnes, P. J. Senotherapy: a new horizon for COPD therapy. Chest 158, 562–570 (2020).
Google Scholar
Zhang, W. G. et al. Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir. Res. 15, 33 (2014).
Google Scholar
Liu, X., Fang, Q. & Kim, H. Preclinical studies of mesenchymal stem cell (MSC) administration in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. PLoS ONE 11, e0157099 (2016).
Google Scholar
Horvath, L. et al. Engineering an in vitro air-blood barrier by 3D bioprinting. Sci. Rep. 5, 7974 (2015).
Google Scholar
Dal Negro, R. W. et al. Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study. Eur. Respir. J. 50, PA675 (2017).
Moretti, M. et al. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study. Drugs Exp. Clin. Res. 30, 143–152 (2004).
Google Scholar
Culpitt, S. V. et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58, 942–946 (2003).
Google Scholar
Beijers, R., Gosker, H. R. & Schols, A. Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope? Curr. Opin. Clin. Nutr. Metab. Care 21, 138–144 (2018).
Google Scholar
Bishwakarma, R. et al. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus. Int J. Chron. Obstruct. Pulmon. Dis. 13, 793–800 (2018).
Google Scholar
Soukas, A. A., Hao, H. & Wu, L. Metformin as anti-aging therapy: is it for everyone? Trends Endocrinol. Metab. 30, 745–755 (2019).
Google Scholar
de Matos Cavalcante, A. G. et al. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. J. Pineal Res. 53, 238–244 (2012).
Google Scholar
Hee Jo, E. et al. Sensitization of GSH synthesis by curcumin curtails acrolein-induced alveolar epithelial apoptosis via Keap1 cysteine conjugation: a randomized controlled trial and experimental animal model of pneumonitis. J. Adv. Res. S2090-1232(22)00152-7 (2022).
Eleazu, C., Eleazu, K. & Kalu, W. Management of benign prostatic hyperplasia: could dietary polyphenols be an alternative to existing therapies? Front. Pharm. 8, 234 (2017).
Google Scholar
Nørgaard, M., Darvalics, B. & Thomsen, R. W. Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study. BMJ Open 10, e041875 (2020).
Google Scholar
Jung, Y. et al. Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells. Oncotarget 8, 87194–87208 (2017).
Google Scholar
Enikeev, D. et al. EAU, AUA and NICE guidelines on surgical and minimally invasive treatment of benign prostate hyperplasia: a critical appraisal of the guidelines using the AGREE-II tool. Urol. Int. 106, 1–10 (2022).
Google Scholar
Wakita, M. et al. A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells. Nat. Commun. 11, 1935 (2020).
Google Scholar
Li, J., Zhao, L., Urabe, G., Fu, Y. & Guo, L. W. Epigenetic intervention with a BET inhibitor ameliorates acute retinal ganglion cell death in mice. Mol. Vis. 23, 149–159 (2017).
Google Scholar
Schwartz, S. D. et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713–720 (2012).
Google Scholar
da Cruz, L. et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat. Biotechnol. 36, 328–337 (2018).
Google Scholar
Mandai, M. et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N. Engl. J. Med. 376, 1038–1046 (2017).
Google Scholar
Carneiro, A. & Andrade, J. P. Nutritional and lifestyle interventions for age-related macular degeneration: a review. Oxid. Med. Cell Longev. 2017, 6469138 (2017).
Merle, B. M. J. et al. Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK Consortium. Ophthalmology 126, 381–390 (2019).
Google Scholar
Richer, S. et al. Resveratrol based oral nutritional supplement produces long-term beneficial effects on structure and visual function in human patients. Nutrients 6, 4404–4420 (2014).
Google Scholar
Yi, C., Pan, X., Yan, H., Guo, M. & Pierpaoli, W. Effects of melatonin in age-related macular degeneration. Ann. N. Y Acad. Sci. 1057, 384–392 (2005).
Google Scholar
Cao, Y. et al. Bioinformatical and biochemical analyses on the protective role of traditional Chinese medicine against age-related macular degeneration. Curr. Eye Res. 47, 1450–1463 (2022).
Lowthian, J. A. et al. Slowing the progression of age-related hearing loss: rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial. Contemp. Clin. Trials 46, 60–66 (2016).
Google Scholar
Robman, L. D. et al. Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial. Contemp. Clin. Trials Commun. 20, 100667 (2020).
Google Scholar
McNeil, J. J. et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N. Engl. J. Med. 379, 1509–1518 (2018).
Google Scholar
Ren, H., Chen, J., Wang, Y., Zhang, S. & Zhang, B. Intracerebral neural stem cell transplantation improved the auditory of mice with presbycusis. Int. J. Clin. Exp. Pathol. 6, 230–241 (2013).
Google Scholar
Corrales, C. E. et al. Engraftment and differentiation of embryonic stem cell-derived neural progenitor cells in the cochlear nerve trunk: growth of processes into the organ of Corti. J. Neurobiol. 66, 1489–1500 (2006).
Google Scholar
Chen, W. et al. Restoration of auditory evoked responses by human ES-cell-derived otic progenitors. Nature 490, 278–282 (2012).
Google Scholar
Wang, J. & Puel, J. L. Toward cochlear therapies. Physiol. Rev. 98, 2477–2522 (2018).
Google Scholar
Seidman, M. D., Khan, M. J., Bai, U., Shirwany, N. & Quirk, W. S. Biologic activity of mitochondrial metabolites on aging and age-related hearing loss. Am. J. Otol. 21, 161–167 (2000).
Google Scholar
Serra, L. S. M. et al. Role of melatonin in prevention of age-related hearing loss. PLoS ONE 15, e0228943 (2020).
Google Scholar
Nevado, J. et al. Ginkgo biloba extract (EGb761) protects against aging-related caspase-mediated apoptosis in rat cochlea. Acta Otolaryngol. 130, 1101–1112 (2010).
Google Scholar
Kang, J. W., Choi, H. S., Kim, K. & Choi, J. Y. Dietary vitamin intake correlates with hearing thresholds in the older population: the Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 99, 1407–1413 (2014).
Google Scholar
Polanski, J. F. & Cruz, O. L. Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial. J. Laryngol. Otol. 127, 134–141 (2013).
Google Scholar
Wyld, L. et al. Senescence and cancer: a review of clinical implications of senescence and senotherapies. Cancers 12, 2134 (2020).
Wang, B., Kohli, J. & Demaria, M. Senescent cells in cancer therapy: friends or foes? Trends Cancer 6, 838–857 (2020).
Google Scholar
Prasanna, P. G. et al. Therapy-induced senescence: opportunities to improve anticancer therapy. J. Natl Cancer Inst. 113, 1285–1298 (2021).
Google Scholar
Bury, M., Le Calve, B., Ferbeyre, G., Blank, V. & Lessard, F. New insights into CDK regulators: novel opportunities for cancer therapy. Trends Cell Biol. 31, 331–344 (2021).
Google Scholar
Gomez, D. L., Armando, R. G., Cerrudo, C. S., Ghiringhelli, P. D. & Gomez, D. E. Telomerase as a cancer target. Development of new molecules. Curr. Top. Med. Chem. 16, 2432–2440 (2016).
Google Scholar
Ramaiah, M. J., Tangutur, A. D. & Manyam, R. R. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Life Sci. 277, 119504 (2021).
Google Scholar
Zhu, H. et al. Oncogene-induced senescence: from biology to therapy. Mech. Ageing Dev. 187, 111229 (2020).
Google Scholar
Nitiss, J. L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 9, 338–350 (2009).
Google Scholar
Cattrini, C., Capaia, M., Boccardo, F. & Barboro, P. Etoposide and topoisomerase II inhibition for aggressive prostate cancer: data from a translational study. Cancer Treat. Res. Commun. 25, 100221 (2020).
Google Scholar
Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789–802 (2006).
Google Scholar
Skok, Z., Zidar, N., Kikelj, D. & Ilas, J. Dual inhibitors of human DNA topoisomerase II and other cancer-related targets. J. Med. Chem. 63, 884–904 (2020).
Google Scholar
Rottenberg, S., Disler, C. & Perego, P. The rediscovery of platinum-based cancer therapy. Nat. Rev. Cancer 21, 37–50 (2021).
Google Scholar
Dasari, S. & Tchounwou, P. B. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharm. 740, 364–378 (2014).
Google Scholar
de Vries, G., Rosas-Plaza, X., van Vugt, M., Gietema, J. A. & de Jong, S. Testicular cancer: determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treat. Rev. 88, 102054 (2020).
Google Scholar
Xiang, M., Colevas, A. D., Holsinger, F. C., Le, Q. X. & Beadle, B. M. Survival after definitive chemoradiotherapy with concurrent cisplatin or carboplatin for head and neck cancer. J. Natl Compr. Canc. Netw. 17, 1065–1073 (2019).
Google Scholar
Rogers, B. B. et al. Oxaliplatin: detection and management of hypersensitivity reactions. Clin. J. Oncol. Nurs. 23, 68–75 (2019).
Hall, A. G. & Tilby, M. J. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev. 6, 163–173 (1992).
Google Scholar
Perez, E. A. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol. Cancer Ther. 8, 2086–2095 (2009).
Google Scholar
Klein, L. E., Freeze, B. S., Smith, A. B. 3rd & Horwitz, S. B. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. Cell Cycle 4, 501–507 (2005).
Google Scholar
O’Leary, B., Finn, R. S. & Turner, N. C. Treating cancer with selective CDK4/6 inhibitors. Nat. Rev. Clin. Oncol. 13, 417–430 (2016).
Google Scholar
Kumarasamy, V., Vail, P., Nambiar, R., Witkiewicz, A. K. & Knudsen, E. S. Functional determinants of cell cycle plasticity and sensitivity to CDK4/6 inhibition. Cancer Res. 81, 1347–1360 (2021).
Google Scholar
Sava, G. P., Fan, H., Coombes, R. C., Buluwela, L. & Ali, S. CDK7 inhibitors as anticancer drugs. Cancer Metastasis Rev. 39, 805–823 (2020).
Google Scholar
Liu, H., Liu, K. & Dong, Z. Targeting CDK12 for cancer therapy: function, mechanism, and drug discovery. Cancer Res. 81, 18–26 (2021).
Google Scholar
Phatak, P. & Burger, A. M. Telomerase and its potential for therapeutic intervention. Br. J. Pharm. 152, 1003–1011 (2007).
Google Scholar
Pascolo, E. et al. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J. Biol. Chem. 277, 15566–15572 (2002).
Google Scholar
Burchett, K. M., Yan, Y. & Ouellette, M. M. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. PLoS ONE 9, e85155 (2014).
Google Scholar
Dhillon, S. Decitabine/cedazuridine: first approval. Drugs 80, 1373–1378 (2020).
Google Scholar
Zhu, Y. et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15, 428–435 (2016).
Google Scholar
Dong, D. et al. Bcl2 inhibitor ABT737 reverses the Warburg effect via the Sirt3-HIF1alpha axis to promote oxidative stress-induced apoptosis in ovarian cancer cells. Life Sci. 255, 117846 (2020).
Google Scholar
Coleman, R. L. et al. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: a pilot clinical and translational study. Gynecol. Oncol. 161, 104–112 (2021).
Google Scholar
Tang, S. M. et al. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed. Pharmacother. 121, 109604 (2020).
Google Scholar
Jia, S. et al. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death Dis. 10, 142 (2019).
Google Scholar
link